TW201219572A - A method to producing a spheroid population of adult stem cells - Google Patents

A method to producing a spheroid population of adult stem cells Download PDF

Info

Publication number
TW201219572A
TW201219572A TW099138813A TW99138813A TW201219572A TW 201219572 A TW201219572 A TW 201219572A TW 099138813 A TW099138813 A TW 099138813A TW 99138813 A TW99138813 A TW 99138813A TW 201219572 A TW201219572 A TW 201219572A
Authority
TW
Taiwan
Prior art keywords
stem cells
cell
chitosan
cells
stem cell
Prior art date
Application number
TW099138813A
Other languages
Chinese (zh)
Other versions
TWI419970B (en
Inventor
Shan-Hui Hsu
Original Assignee
Univ Nat Taiwan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nat Taiwan filed Critical Univ Nat Taiwan
Priority to TW099138813A priority Critical patent/TWI419970B/en
Priority to CN201110355162.3A priority patent/CN102533640B/en
Publication of TW201219572A publication Critical patent/TW201219572A/en
Application granted granted Critical
Publication of TWI419970B publication Critical patent/TWI419970B/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

This invention relates to a method to producing a spheroid cell population of adult stem cells, comprising culturing adult stem cells on a thin film made by biocompatibility polymer materials. The biocompatibility polymer materials is chitosan, alginate, hyaluronic acid, tremella polysaccharide, polycaprolactone or any combination thereof. The adult stem cells are selected from the group consisting of neural stem cells, neural progenitor cells, adipose-derived adult stem cells, human gingival fibroblasts, bone mesenchymal stem cells, lung stem cell and placenta-derived mesenchymal stem cells. The method can sustain the self-renew and stemness of adult stem cells.

Description

201219572 ,六、發明說明: 【發明所屬之技術領域】 本發明係關於一種成體幹細胞之培養方法,尤其是有關一種應用 生物相容性高分子使成體幹細胞聚集成球體且分化能力提升的方法。 【先前技術】 幹細胞為一種尚未分化完全的細胞,具有自我更新(self-renew)與分 化的可塑性,在組織工程以及再生醫學的應用上極具潛力;幹細胞根 ^ 據分化的潛能,分為全能幹細胞(totipotent stem cells)、三胚層多能幹細 胞(multipotent stem cells)、單胚層多潛能幹細胞(pluripotent stem cells) 與單能幹細胞(unipotent stem cells) ’例如:桑椹胚(morula)之前的每 個細胞都保有全能性,也就是將任一個細胞放在子宮中都可以發育成 一個完整的個體,具這種潛能的細胞稱為全能幹細胞。單獨只有内細 胞團塊(inner cell mass)的細胞,雖然無法發育成整個個體(因為缺乏 分化成滋養外胚層的能力,滋養外胚層之後會分化成羊膜和胎盤),但 具有發展成個體過程中分化為各種細胞的能力,稱為三胚層多能幹細 胞。間簠幹細胞(mesenchymal stem cells, MSCs)能分化成硬骨、軟骨、 Φ 脂肪和其他結締組織或轉分化為神經細胞、肝臟細胞等,稱為單胚層 多潛能幹細胞。神經幹細胞(neural stem cell)只能分化成神經元或是神 經膠細胞,稱為單能幹細胞。 幹細胞又可依來源分為胚胎幹細胞(embryonic stem cells,ESCs)和 成體幹細胞(adult stem cells)。胚胎幹細胞通常是指來自囊胚内細胞團的 細胞,成體幹細胞一般係指取自嬰兒出生後的幹細胞。成體幹細胞包 括但不限於造血幹細胞(hemat〇P〇ietic stem cell)、間葉幹細胞、神經幹 細胞(neural stem cells,NSCs)、肝幹原細胞(oval cdl)等。其中間葉幹細 胞又依來源包括但不限於骨髓間葉幹細胞(BMSCs)、胎盤幹細胞 4 201219572 (placenta-derived mesenchymal stem cells,PDMSCs)、脂肪幹細胞 (adipwderived adult stem cells,ADASs)、牙齦幹細胞(Human gingivai fibroblasts,HGF)等等。 胚胎幹細胞具有無限次的複製能力和多潛能性的分化潛能,然而 其臨床應用上卻有許多待克服的問題,例如道德上的爭議以及移植時 會產生免疫排斥等等。成體幹細胞則因臨床上多採自體移植的應用方 式,可避免移植時產生免疫排斥的問題及道德上的爭議之優點,然而 成體幹細胞也因分裂次數有限,通常僅能分化成少數幾種細胞,如神 經幹細胞經適當的條件下可分化為神經元(neur〇ns)、星狀膠質細胞 (astrocytes)以及养樹突膠質細胞(〇iig〇(jendroCytes、)’且成體幹細胞在體 外增瘦培養過程中,常會產生不易維持分化活性及功能性的問題。 另一方面’一般習知適合培養幹細胞的材料以聚苯乙烯 (polystyrene)、明膠(gelatin)、聚_α_羥基酸、聚乳酸乙醇酸等,其具有穩 定生物適應性的優點,但該些材料用於成體幹細胞的增殖培養過程, 有不易分化及或喪失功能的缺點,影響成體幹細胞增殖分化的成效。 目前研究已發現細胞形態可調節幹細胞治療前分化因子的·|善系, 而球體的細胞形態已被證實與分化潛能有關’例如胚胎幹細胞聚集的 群落自緊密的細胞-細胞接觸可以細胞自我更新;胚胎體(Embryoid bodies,EB)為胚胎幹細胞三度空間細胞聚集,可在模擬的正常胚胎生長 環境下初始分化,但目前仍未有成體幹細胞聚集為球體之有效方法。 【發明内容】 為解決習知成體幹細胞體外培養不易維持幹性(sternness)及分化之 問題’本發明之目的係提供一種使成體幹細胞產生為一球體細胞群體 的方法’包含體外培養成體幹細胞於一生物相容性高分子形成的一薄 201219572 ,膜上’其中該生物相容性高分子係為幾丁聚醣、褐藻酸鹽、透明質酸、 聚己内酯、銀耳多醣或其任一組合;以及收集由成體幹細胞聚集成之 一球體細胞群體’其中該球體細胞群體會擴大且具有自我更新及分化 為一體細胞的能力;該成體幹細胞選自由神經幹細胞、神經前驅細胞、 脂肪幹細胞、牙齦幹細胞、骨髓間葉幹細胞、肺幹細胞及胎盤幹細胞 所組成之群組,而生物相容性高分子可為幾丁聚醣與透明質酸的組 合,且幾丁聚醣與透明質酸的比例(w/w)約為3/0.177至3/4.425,因本 發明使用 〇.lmg/cm2, 〇.5mg/cm2, 2_5 mg/cm2,因為一個玻片 1.77 cm2,所 以是 3 mg (chitosan) :〇.177mg (HA), 3 mg (chitosan):0.885 mg (HA),3 鲁 mg (chitosan):4.425 mg (HA)都有效,是利用透明質酸負電吸附在幾丁醣 (正電)表面的雙層材料,否則透明質酸抓不住表面會溶到水中,該體細胞 可為一神經細胞。另一方面’由成體幹細胞產生的該球體細胞群體進 一步具有轉分化(transdifferentiation)為一心肌細胞或一軟骨細胞的能 力,其中當該球體細胞群體為脂肪幹細胞時,使脂肪幹細胞與 5-azacytidine接觸會轉分化為心肌細胞;而當該球體細胞群體為牙齦幹 細胞、脂肪幹細胞、或胎盤幹細胞時,使前述細胞與一轉型生長因子 P3(TGF-p3)接觸會轉分化為軟骨細胞。 • 本發明之另一目的為提供一種具有分化能力的成體幹細胞,係由 以下方法所製成,包含使一成體幹細胞與一生物相容性高分子形成的 一薄膜接觸一段有效時間,其中該生物相容性高分子係為幾丁聚酶、 褐藻酸鹽、透明質酸或其任一組合;其中該成體幹細胞會形成一球體 細胞群體,該球體細胞群體會擴大並具有轉分化為一軟骨細胞或一心 肌細胞的能力;該成體幹細胞選自由神經幹細胞、神經前驅細胞、脂 肪幹細胞、牙齦幹細胞、及胎盤幹細胞所組成之群組,而生物相容性 高分子可進一步包含一具有如SEQ ID ΝΟ:1胺基酸序列之纖維素結合 功月&區域-RGD 貼附序列(cellulose binding domain-RGD, CBD-RGD)能 201219572 提昇球體細麟體的轉分化能力;生物相容性高分子或可為幾丁聚糖 與透明質酸的組合,且幾丁聚醣與透明質酸的比例約為3: 〇 i . 4.425(W/W);可為幾τ聚贿銀耳多醣的組合,且幾丁聚醣與銀耳多糖 的比例約為3 . G.4至3 : 4.5(w/w);亦可為聚己_與透明f酸的組合. 該體細胞可為一神經細胞。 σ, 本發明之又—目的為提供—«藥組合物,包含前述之成體幹,田 胞及-鮮上可接受鑛。紐可為_彳(如水)、填·(如趣 或麟)、黏合劑(如纖維素衍生物)、稀釋劑、崩解劑、吸收促進劑 或甜補,但並未舰於此。本判錢組錢可依—般習知幹細胞 療法樂劑之製備方法生產製造’將本發明成體幹細胞與—種以上之 體相混合,製備出所需之劑型,此劑型可包括錠劑、粉劑、粒劑、 膠囊或其他液體㈣’但未以此為限。本發_賴組合物可庫 用於臨床上幹細胞療法,以促進神經細胞、峨細胞錄骨細胞的再 生,亦可藉此包含祕幹細胞的醫藥組合物來避免胚胎幹細胞取 得不易及倫理上的考量。 本發明之伽為提供-的舰動物纽成體幹細胞、其醫藥 組合物、以於生越成體幹細胞的方法,係藉由生物相容性高分 子接觸而達到自我更新及維持幹性(stemness)的突出效果。 以下將配合圖歧-步制本發_實施枝,下述所列舉的實 施例係肋_本發明,並_雜定本㈣之個,任何熟習此技 藝者’在不脫離本發明之精神和範圍内,#可做些許更動與潤飾,因 此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 【實施方式】 本發明實關使賴天齡物相雜高分子為幾了雜、褐藻酸 201219572 • 鹽、透明質酸或其任一組合,其中幾丁聚醣(咖_)由胺基多醣類 (amin〇_p〇lySaccharide)所組成’幾丁聚醣包含與細胞外間質相同成分的 葡萄糖胺多酿(glyCosamino-glycan),所以生物相容性高且為生物可分解 的材料。褐藻酸鹽(alginate)為一可增進神經軸突再生的天然軟質聚合 物,褐藻酸鹽可在生理條件(於室溫或是體溫、生理pH值以及等滲透 壓)下與辦離子交聯;褐藤酸妈(calciumalginate)為一生物可相容性和無 致免疫性’所以為面穩定性以及兩生物相容性的材料。透明質酸 (hyaluronic acid,HA)可增進細胞遷移(migration)、增殖以及間質分泌的 材料,且為水溶性不會形成薄膜,在本發明中是與幾丁聚糖組合形成 ® 一薄膜。因此’本發明係揭露前述生物相容性高分子應用於成體幹細 胞培養的新賴方法。 本發明實施例使用的成體幹細胞為神經幹細胞、神經前驅細胞、 脂肪幹細胞、牙齦幹細胞、及胎盤幹細胞,經與前述的生物相容性高 分子形成之薄膜接觸,會使該些成體幹細胞聚集形成一球體細胞群 體’且本發明的球體細胞群體以胰蛋白酶(trypsin)處理是會整粒球由薄 膜上脫離’若只是先前文獻提及的幹細胞聚集現象,用胰蛋白酶(trypsin) 處理是一顆一顆細胞分開脫離。 ® 本發明的各實施例中,實施例1及2為利用不同分子量的幾丁聚 醣和不同Μ/G比的褐藻酸鹽製成二度空間(2D)薄膜,比較神經幹細胞 培養於其上和其他習知材料(ex.TCPS)之形態及分化結果比較。實施例 3-5為利用不同分子量的幾丁聚醣、改質之幾丁聚醣、或與透明質酸結 合的幾丁聚醣膜分別培養脂肪幹細胞、牙齦幹細胞、包皮纖維母細胞 或是胎盤幹細胞,與培養於其他習知材料(ex.TCPS)之形態以及分化結 果比較。實施例6為利用幾丁聚醣-銀耳多醣培養脂肪幹細胞與神經幹 細胞,觀察其形態。 本發明之一實施例係藉由分析神經幹細胞及神經前驅細胞在不同 201219572 材料上之型態與分化,判斷其自我更新及幹性維持與否;其中不同材 料係以去乙醯度、表面電位、及水接觸角分析各材料產生出球體細胞 群體的效果。進一步並確認球體細胞群體的細胞型態以及分化的效 果’其中F1B-螢光綠蛋白(F1B-GFP)在未分化的神經幹細胞會表現出綠 色螢光,因此神經幹細胞分化的分析係偵測F1B_螢光綠蛋白的表現, 進而配合免疫螢光偵測神經幹細胞的標記nestin及未發育完全神經元 的標記 β3-tubulin。 在本發明中所使用者’ ”一神經幹細胞,,或"一神經前驅細胞”係指未 分化的中柩神經(CNS)多能幹細胞。 “一具有分化能力的成體幹細胞,,係指一成體幹細胞容易分化為多 種類的體細胞。依照本發明的方法處理成體幹細胞,能使成體幹細胞 具有自我更新及分化的能力,提升成體幹細胞的可塑性。 ‘‘一段有效時間”係指生物相容性高分子與本發明的成體幹細胞形 成一球體細胞群體所必需的一段時間,例如神經幹細胞與幾丁聚糖接 觸一段時間使其聚集形成球體。關於與生物相容性高分子接觸的一段 有效時間,在本說明書中可為4個小時到14曰或更多,較佳為〗曰到 4曰。 藥子上可接受載體”係指用於達成或增進本發明醫藥組合物成 功遞送的物質,可為賦形劑(如水)、填充劑(如蔗糖或澱粉)、黏合 劑(如纖維素衍生物)、稀釋劑、崩解劑、吸收促進劑或甜味劑,但並 未僅限於此。 “約”約略”或”近似地”一般係指20%,較佳為1〇%,最佳為5% 的範圍内。本文中的數值係為近似值,在未明確定義的情況下可隱含 「約」「約略」或「近似地」之含義。 “一”係指一個或一個以上(即是至少一個)的冠詞文法受詞。舉例 201219572 -而言,“一細胞”係指一個細胞或一個以上的細胞。 本發明實施例中測量生物相容性高分子表面電位之分析方法’準 備4cmM.5 cm的薄膜,利用表面電位分析儀(Beckman Coulter)測其 表面電位(mV,Surface zeta potential)。 本發明實施例所用之神經幹細胞免疫螢光染色方法,為量測幾丁 聚醣膜上神經幹細胞球的分化狀態,細胞標記(nestin,標記於神經幹細 胞;p3-tubulin,標記於神經元)用於免疫螢光染色。在細胞培養不同週期 時間被固定於4%仲甲酸(paraformaldehyde)中。以構酸鹽緩衝液潤洗三 鲁 次。加入 0.5% Triton X-100 (t-octylphenoxypolyethoxyethanol, Sigma, USA)50〇W 10分鐘以破壞細胞膜及核膜。以磷酸鹽緩衝液潤洗樣本幾 次,加入20μ1 —級抗體於暗室37°C培養置放1小時。為將細胞染色, 加入0.1%之4,6-聯脒-3-笨°弓卜朵二鹽酸鹽(4,6-出3111丨£1丨11〇-2-卩11611>4丨1^〇16 dihydrochloride)(購於 DAPI,Sigma, D9542, USA)200pl 於暗室 30 分鐘。 最後,潤洗樣本後將其架於顯微鏡載玻片上,以甘油凝膠密封。樣本 於正立式螢光顯微鏡觀察(購於Nikon,80i)。一級抗體稀釋比例如下: anti-nestin (R-20) goat-poly IgG 抗體(購於 Santa Cruz, USA; 1:1000) 以及 anti-p3-tublin mouse-mono IgG (購於 Santa Cruz,USA; 1:1000)。二 参 級抗體稀釋比例為FITC-conjugated goat anti-mouse IgG (以馬血清蛋白 稀釋;1:100;購於 Chemicon,CA)以及 goat anti-rabbit IgG-horeseradish peroxidase (HRP)(購於 Santa Cruz, USA; 1:100)。201219572, sixth, invention description: [Technical field of the invention] The present invention relates to a method for culturing adult stem cells, and more particularly to a method for using a biocompatible polymer to aggregate adult stem cells into spheres and to improve differentiation ability . [Prior Art] Stem cells are cells that have not yet fully differentiated, have self-renew and differentiated plasticity, and have great potential in tissue engineering and regenerative medicine applications; stem cell roots are divided into omnipotents based on their potential for differentiation. Totipotent stem cells, three-potential pluripotent stem cells, pluripotent stem cells, and unipotent stem cells 'eg each cell before morula All have versatility, that is, any cell can be developed into a complete individual in the uterus, and cells with this potential are called pluripotent stem cells. Cells with only inner cell mass alone, although unable to develop into the entire individual (because of the lack of ability to differentiate into trophectoderm, will differentiate into amniotic membrane and placenta after trophoblast development), but have evolved into individual processes The ability to differentiate into various cells, called the three germ layer pluripotent stem cells. Mesenchymal stem cells (MSCs) can differentiate into hard bone, cartilage, Φ fat and other connective tissues or transdifferentiate into nerve cells, liver cells, etc., called single germ layer pluripotent stem cells. Neural stem cells can only differentiate into neurons or neuroglial cells, called pluripotent stem cells. Stem cells can be further classified into embryonic stem cells (ESCs) and adult stem cells according to sources. Embryonic stem cells generally refer to cells derived from the inner cell mass of the blastocyst, and adult stem cells generally refer to stem cells taken from the baby's birth. Adult stem cells include, but are not limited to, hemat〇P〇ietic stem cells, mesenchymal stem cells, neural stem cells (NSCs), hepatic stem cells (oval cdl), and the like. Among them, mesenchymal stem cells include but are not limited to bone marrow mesenchymal stem cells (BMSCs), placenta stem cells 4 201219572 (placenta-derived mesenchymal stem cells (PDMSCs), adipodderd adult stem cells (ADASs), and gingival stem cells (Human gingivai). Fibroblasts, HGF) and more. Embryonic stem cells have unlimited replication ability and pluripotency differentiation potential. However, there are many problems to be overcome in clinical application, such as moral controversy and immune rejection during transplantation. Adult stem cells can avoid the problem of immune rejection and the moral controversy during transplantation because of the clinical application of autologous transplantation. However, adult stem cells are usually only able to differentiate into a few due to limited number of divisions. Seed cells, such as neural stem cells, can be differentiated into neurons (neur〇ns), astrocytes (astrocytes) and dendritic cells (〇endigCytes,) and adult stem cells in vitro under appropriate conditions. In the process of weight-increasing culture, it is often difficult to maintain the differentiation activity and functionality. On the other hand, 'the general materials suitable for culturing stem cells are polystyrene, gelatin, poly-α-hydroxy acid, Polylactic acid glycolic acid, etc., has the advantages of stable biocompatibility, but these materials are used for the proliferation and culture process of adult stem cells, have the disadvantage of being difficult to differentiate or lose function, and affect the effect of adult stem cell proliferation and differentiation. It has been found that cell morphology can regulate the differentiation of stem cells before treatment, and the cell morphology of the sphere has been confirmed and the differentiation potential has For example, the colony of embryonic stem cells can self-renew from tight cell-cell contact; Embryoid bodies (EB) are three-dimensional spatial cell aggregates of embryonic stem cells, which can be initially differentiated under simulated normal embryo growth environment, but There is still no effective method for aggregating adult stem cells into spheres. SUMMARY OF THE INVENTION In order to solve the problem that conventional adult stem cells are difficult to maintain sternness and differentiation in vitro, the object of the present invention is to provide an adult stem cell The method of a spheroid cell population comprises the in vitro culture of adult stem cells in a thin layer of 201219572 formed on a biocompatible polymer, wherein the biocompatible polymer is chitosan, alginate, transparent Acidic acid, polycaprolactone, tremella polysaccharide or any combination thereof; and the ability to collect a population of spheroid cells aggregated by adult stem cells, wherein the spheroid cell population expands and has the ability to self-renew and differentiate into one cell; Adult stem cells are selected from the group consisting of neural stem cells, neural precursor cells, adipose stem cells, and dried gingiva a group consisting of cells, mesenchymal stem cells, lung stem cells, and placental stem cells, and the biocompatible polymer can be a combination of chitosan and hyaluronic acid, and the ratio of chitosan to hyaluronic acid ( w/w) is about 3/0.177 to 3/4.425, since the present invention uses l.lmg/cm2, 5.5mg/cm2, 2_5 mg/cm2, because a slide is 1.77 cm2, so it is 3 mg (chitosan): 177.177mg (HA), 3 mg (chitosan): 0.885 mg (HA), 3 ru mg (chitosan): 4.425 mg (HA) are effective, using hyaluronic acid negatively adsorbed on the surface of chitosan (positive) The double-layer material, otherwise the hyaluronic acid can not grasp the surface will dissolve into the water, the somatic cell can be a nerve cell. On the other hand, the population of spheroid cells produced by adult stem cells further has the ability to transdifferentiation into a cardiomyocyte or a chondrocyte, wherein when the spheroid cell population is adipose stem cells, the adipose stem cells are incubated with 5-azacytidine. The contact is transdifferentiated into cardiomyocytes; and when the spheroid cell population is gingival stem cells, adipose stem cells, or placental stem cells, the cells are transdifferentiated into chondrocytes by contact with a transforming growth factor P3 (TGF-p3). • Another object of the present invention is to provide an adult stem cell having differentiation ability, which is produced by contacting a thin stem cell with a biocompatible polymer for an effective period of time, wherein The biocompatible polymer is chitinase, alginate, hyaluronic acid or any combination thereof; wherein the adult stem cells form a spheroid cell population, and the spheroid cell population expands and has a transdifferentiation to The ability of a chondrocyte or a cardiomyocyte; the adult stem cell is selected from the group consisting of a neural stem cell, a neural precursor cell, a fat stem cell, a gingival stem cell, and a placental stem cell, and the biocompatible polymer may further comprise a The cellulose binding domain-RGD ( CBD-RGD) of the SEQ ID ΝΟ:1 amino acid sequence can enhance the transdifferentiation ability of the spheroids of the spheroids; biocompatible The polymer may be a combination of chitosan and hyaluronic acid, and the ratio of chitosan to hyaluronic acid is about 3: 〇i. 4.425 (W/W); The combination of polyglycoside polysaccharide, and the ratio of chitosan to tremella polysaccharide is about 3. G. 4 to 3: 4.5 (w / w); can also be a combination of poly- and transparent f acid. Can be a nerve cell. σ, Still another object of the present invention is to provide a pharmaceutical composition comprising the aforementioned adult stem, field cell and freshly acceptable mineral. Newcomers are _ 彳 (such as water), filling (such as fun or Lin), adhesives (such as cellulose derivatives), thinners, disintegrants, absorption enhancers or sweet supplements, but not in the ship. The money of the money-making group can be produced according to the preparation method of the conventional stem cell therapeutic agent. The adult stem cells of the present invention are mixed with the body of the above-mentioned body to prepare a desired dosage form, and the dosage form may include a tablet, Powder, granules, capsules or other liquids (4) 'but not limited to this. The present invention can be used for clinical stem cell therapy to promote the regeneration of nerve cells and sputum cells, and the pharmaceutical composition containing secret cells can be used to avoid the difficulty and ethical consideration of embryonic stem cells. . The invention provides a marine animal stem cell, a pharmaceutical composition thereof, and a method for growing an adult stem cell, which is self-renewing and maintaining dryness by contact with a biocompatible polymer (stemness) ) The outstanding effect. In the following, the embodiment will be described in conjunction with the embodiment of the present invention, and the following examples are given to the present invention, and the present invention can be used without departing from the spirit and scope of the present invention. In the meantime, # may be modified and retouched, and the scope of protection of the present invention is defined by the scope of the appended claims. [Embodiment] The present invention makes Lai Tianling's phase heteropolymers a few impurities, alginic acid 201219572 • salt, hyaluronic acid or any combination thereof, wherein chitosan (coffee) is composed of aminopolysaccharides (amin〇_p〇lySaccharide) The composition of chitosan contains glyCosamino-glycan which is the same component as the extracellular matrix, so it is biocompatible and biodegradable. Alginate is a natural soft polymer which can promote the regeneration of axons. Alginate can be cross-linked with physiological ions under physiological conditions (at room temperature or body temperature, physiological pH and isotonic pressure); Calcium alginate is a biocompatible and non-immunogenic one, so it is a surface stability and two biocompatible materials. Hyaluronic acid (HA) is a material that promotes cell migration, proliferation, and interstitial secretion, and does not form a film for water solubility. In the present invention, it is combined with chitosan to form a film. Therefore, the present invention discloses a novel method for applying the aforementioned biocompatible polymer to adult stem cell culture. The adult stem cells used in the embodiments of the present invention are neural stem cells, neural precursor cells, adipose stem cells, gingival stem cells, and placental stem cells, which are brought into contact with a film formed by the aforementioned biocompatible polymer to cause aggregation of the adult stem cells. Forming a spheroid cell population' and treating the spheroid cell population of the present invention with trypsin is the detachment of the globular globule from the membrane. If only the stem cell aggregation phenomenon mentioned in the prior literature is used, treatment with trypsin is one. One cell separates. In each of the embodiments of the present invention, Examples 1 and 2 are two-dimensional (2D) films made of chitosan having different molecular weights and alginate having different Μ/G ratios, and the neural stem cells are cultured thereon. Compare with the morphology and differentiation results of other conventional materials (ex.TCPS). Example 3-5 is to culture adipose stem cells, gingival stem cells, foreskin fibroblasts or placenta by using chitosan of different molecular weight, modified chitosan, or chitosan membrane combined with hyaluronic acid. Stem cells were compared with the morphology of cultured other known materials (ex. TCPS) and differentiation results. Example 6 was to culture adipose stem cells and neural stem cells using chitosan-white fungus polysaccharide, and observe the morphology thereof. One embodiment of the present invention determines the self-renewal and dryness maintenance of neural stem cells and neural precursor cells on different 201219572 materials; the different materials are de-acetylated, surface potential And water contact angle analysis of each material produces a spherical cell population effect. Further confirm the cell type and differentiation effect of the spheroid cell population. 'F1B-fluorescent chloroplast (F1B-GFP) will show green fluorescence in undifferentiated neural stem cells, so the analysis of neural stem cell differentiation detects F1B. _ Fluorescent green protein performance, combined with immunofluorescence to detect neural stem cells labeled nestin and undeveloped neurons labeled β3-tubulin. In the present invention, a human neural stem cell, or "a neural precursor cell" refers to an undifferentiated middle phrenic nerve (CNS) pluripotent stem cell. "An adult stem cell with differentiation ability means that an adult stem cell is easily differentiated into a plurality of types of somatic cells. The treatment of adult stem cells according to the method of the present invention enables the adult stem cells to have the ability to self-renew and differentiate, and enhance Plasticity of adult stem cells. ''A set of effective time' refers to the period of time necessary for the biocompatible polymer to form a spheroid cell population with the adult stem cells of the present invention, for example, the neural stem cells are in contact with chitosan for a period of time. It aggregates to form a sphere. The effective time for contact with the biocompatible polymer may range from 4 hours to 14 Torr or more, preferably from 曰 to 4 本 in the present specification. "Pharmaceutically acceptable carrier" means a substance used to achieve or enhance the successful delivery of a pharmaceutical composition of the invention, and may be an excipient (such as water), a filler (such as sucrose or starch), a binder (such as a cellulose derivative). , diluent, disintegrant, absorption enhancer or sweetener, but not limited thereto. "About" or "approximately" generally means 20%, preferably 1%, preferably Within 5% of the range. Numerical values herein are approximate and may imply the meaning of "about" or "approximately" if not explicitly defined. "一" means one or more (ie, at least one) grammatical vocabulary. Example 201219572 - "One cell" refers to one cell or more than one cell. In the embodiment of the present invention, a method for measuring the surface potential of a biocompatible polymer was prepared, and a film of 4 cm M. 5 cm was prepared, and its surface potential (mV, Surface zeta potential) was measured by a surface potential analyzer (Beckman Coulter). The neural stem cell immunofluorescence staining method used in the embodiments of the present invention is for measuring the differentiation state of the neural stem cell sphere on the chitosan membrane, and the cell marker (nestin, labeled with neural stem cells; p3-tubulin, labeled with neurons) Immunofluorescence staining. It was fixed in 4% paraformaldehyde at different cycle times in cell culture. Rinse three times with acid buffer. 0.5% Triton X-100 (t-octylphenoxypolyethoxyethanol, Sigma, USA) was added for 50 minutes for 10 minutes to destroy the cell membrane and nuclear membrane. The sample was rinsed with phosphate buffer several times, and 20 μl of the grade antibody was added to the dark chamber for 37 hours at 37 ° C for 1 hour. To stain the cells, add 0.1% of 4,6-biindole-3-bendobate dihydrochloride (4,6-out 3111丨£1丨11〇-2-卩11611>4丨1^ 〇16 dihydrochloride) (purchased from DAPI, Sigma, D9542, USA) 200 pl in the dark room for 30 minutes. Finally, the sample was rinsed and placed on a microscope slide and sealed with glycerin gel. The sample was observed under an upright fluorescent microscope (purchased from Nikon, 80i). The dilution ratio of the primary antibody was as follows: anti-nestin (R-20) goat-poly IgG antibody (purchased from Santa Cruz, USA; 1:1000) and anti-p3-tublin mouse-mono IgG (purchased from Santa Cruz, USA; :1000). The dilution ratio of the two reference antibodies was FITC-conjugated goat anti-mouse IgG (diluted with horse serum albumin; 1:100; purchased from Chemicon, CA) and goat anti-rabbit IgG-horeseradish peroxidase (HRP) (purchased from Santa Cruz, USA; 1:100).

本發明實施例對於心肌分化能力的分析係利用正立螢光顯微鏡 (NIKON).樣品以破酸鹽緩衝液潤洗’加入4 % paraformaldehyde室溫 下固定20分鐘,以磷酸鹽緩衝液清洗3次,每次1〇分鐘,加入3 % bsa/ 構酸鹽緩衝液室溫下30分鐘後,吸出,加入3 % BSA配製的一抗,稀 釋倍率為下表’以parafilm封住後放入4t冰箱過夜;隔天,將一抗 吸出,以磷酸鹽緩衝液潤洗三次(以下步驟全程避光),加入3 % BSA 201219572 配製的一抗’以銘$紙蓋住避光後放入π。。培養箱^小時;將二抗吸 出’碟酸鹽緩衝液潤洗三次,加入3 % BSA西己製的DApi染劑3分鐘, 吸出’抓鹽緩衝液清洗三次後,加入填酸鹽緩衝液,利用針頭與炎 子將材料從24孔培養板取出,放置於載玻片上以正立營光顯微鏡(購於 NIKON)觀察之。 本發明實;^例所分析細胞表面蛋自特徵,係使用之流式細胞儀分 析方法,利用流式細胞儀(購於置&肪,即,說)。首先,將細胞從 培養盤上取下來,取5x1〇5 酸鹽簡液清洗,以1刪啊 離〜5 77釦,重複二次後收集細胞,加入ι〇〇μ1磷酸鹽緩衝液回溶細 胞後’在細胞液中加入1〇μ1 一抗,反應3〇〜6〇分鐘,構酸鹽缓衝液潤 洗三次後,避光下加入10μ1二抗反應3〇〜6〇分鐘,以截鹽緩衝液清 洗’ 1000 rpm離心5分鐘,重複三次以移除未反應之抗體最後加入 5〇Ρμ1磷酸鹽緩衝液回溶細胞,即可移至流式細胞儀進行分析。 前述该些分析結果係以平均值±標準差表示之,並使用t檢定(t-test) 作統計數據分析,當P值小於0.05則具有統計上意義的差異性。 以下,本發明將結合各種實例詳細敘述。這些實例僅提供作為例 示目的,並非推斷本發明限於這些實例。另外,儘管在實例中例示成 體幹細胞中的神經幹細胞、神經前驅細胞及脂肪幹細胞自鼠分離而 來,牙銀幹細胞、胎盤幹細胞自人類分離而來,但本發明不可侷限於 此,而是可應用於自包含人類、大鼠、小鼠及猴等哺乳類動物分離而 來者。 實施例1 以二種分子量之幾丁聚醣薄膜培養成體神經幹細胞/神經前驅細胞 1.1幾丁聚醣薄骐製備 201219572 利用二種幾丁聚醣-1(購於Fluka,USA)及幾丁聚醣-2(購於Sigma, USA)各自配製濃度為1%的幾丁聚醣,係秤取〇 5g幾丁聚醣粉末溶入 於49.5ml 一次水’室溫下擾摔半小時後加入〇.5ml乙酸,並於室溫中 輕拌12小時。隔天使用濾網過濾雜質即為1%幾丁聚醣溶液,其中幾 丁聚醣-1的分子量約為510kDa’幾丁聚醣-2的分子量約為400kDa。 將所得溶液以ΙΟΟμηι的網目過濾,再塗佈於玻璃蓋玻片上(每片直徑 15mm玻片塗佈ΙΟΟμΙ溶液),並晾乾兩天。將幾丁聚醣膜浸入〇5Ν NaOH溶液中5分鐘,再以蒸餾去離子水大面積潤洗直到薄膜附近的水 之酸鹼值達到中性(neutral)。最後,將該幾丁聚醣膜充分晾乾。 1.2鼠腦神經幹細胞萃取及培養 由基因轉殖鼠含啟動子F1B-螢光綠蛋白(F1B-GFP)基因的腦部分 離出神經幹細胞。兩個月大的小白鼠整個腦部絞碎再輕磨成更小碎 塊’取得單一細胞懸浮液。絞碎的細胞植入35-mm無補充基質和附著 力因子的培養血中,以DMEM/F-12培養基(Dulbecco,s modified Eagle,s medium and Ham’s F-12,構於 Giboco, USA) 1:1 培養液含 ι〇%胎牛血清 (fetal bovine serum, FBS)(購於Gibco, USA) 〇兩天後,每個培養皿有將 近10-20個細胞進行細胞分裂。以胰蛋白酶處理後將其集中,並繼續培 養2-3天。進一步用由200pg/ml的糖甘類抗生素geneticin(G4l8,購於 Gibco)挑選出穩疋的細胞系(cell line)。以流式細胞儀(FACS Aria,購於 BD Biosciences)重複純化GFP-陽性的鼠腦細胞至純度達95%以上。 1.3神經幹細胞/神經前驅細胞於幾丁聚醣薄膜之形態分析與分化為神 經細胞的情形 將神經幹細胞植入培養材料前,玻璃蓋玻片上之幾丁聚醣膜浸於 75%乙醇,再以填酸鹽緩衝液(phosphate buffered saline,PBS)、;間洗,然 後放進24孔培養板的每一孔中。神經幹細胞植入密度為每孔5x1 〇4個 細胞。用DMEM/F-12培養基添加10%的胎牛企清(購於Gibco, USA), 12 201219572 40(^g/ml糖甘類抗生素(G418)以及鏈黴素-青黴素(lOOU/ml)作為培養 液。培養於溫度37 C ’ 5°/。CO;?的加濕培養箱’每週更換培養液兩次; 另外並以未加生長因子的聚苯乙烯組織培養板(tissue culture polystyrene surface,TCPS)及明膠(gelatin)作為對照組,結果如第一圖及 第二圖所示。The analysis of the myocardial differentiation ability of the examples of the present invention is performed by using a Orthogonal Fluorescence Microscope (NIKON). The sample is rinsed with a buffer buffer. Adding 4% paraformaldehyde for 20 minutes at room temperature, and washing 3 times with phosphate buffer. Each time 1 minute, add 3% bsa / citrate buffer for 30 minutes at room temperature, aspirate, add 3% BSA prepared primary antibody, the dilution ratio is the following table 'sealed in parafilm and placed in 4t refrigerator Overnight; the next day, the primary antibody was aspirated and rinsed three times with phosphate buffer (the following steps were protected from light), and the primary antibody prepared by adding 3% BSA 201219572 was covered with ITO and placed in π. . The incubator was incubated for 2 hours; the secondary antibody was aspirated and washed three times with the discate buffer, and the DApi dye of 3% BSA was added for 3 minutes. After sucking out the salt buffer for three times, the acid buffer was added. The material was taken out from the 24-well culture plate using a needle and an inflammatory tract, and placed on a glass slide and observed by a Orthodox light microscope (purchased from NIKON). The cell surface self-characteristic of the cell surface analyzed by the present invention is a flow cytometry method using a flow cytometer (purchased in & fat, that is, said). First, remove the cells from the culture plate, take 5x1〇5 acid salt solution, remove 1~77 knots, repeat the second time, collect the cells, add ι〇〇μ1 phosphate buffer to reconstitute the cells. After adding '1 μμl primary antibody to the cell solution, the reaction was 3 〇~6 〇 minutes, and the acid buffer was rinsed three times, and 10 μl of the secondary antibody was added in the dark for 3 〇~6 〇 minutes to cut off the salt buffer. The liquid was washed by centrifugation at 1000 rpm for 5 minutes, repeated three times to remove unreacted antibody, and finally added to 5 μl of phosphate buffer to reconstitute the cells, and then transferred to a flow cytometer for analysis. The above analysis results are expressed as mean ± standard deviation, and t-test is used for statistical analysis. When the P value is less than 0.05, there is a statistically significant difference. Hereinafter, the present invention will be described in detail in conjunction with various examples. These examples are provided for illustrative purposes only, and are not intended to limit the invention to these examples. In addition, although it is exemplified in the examples that neural stem cells, neural precursor cells, and adipose stem cells in adult stem cells are isolated from mice, dental silver stem cells and placental stem cells are isolated from humans, but the present invention is not limited thereto but may be It is applied to the isolation of mammals such as humans, rats, mice and monkeys. Example 1 Cultivation of adult neural stem cells/neural precursor cells 1.1 chitosan thinner by two molecular weight chitosan films 201219572 Using two chitosan-1 (purchased from Fluka, USA) and several Glycan-2 (purchased from Sigma, USA) was prepared with 1% chitosan at a concentration of 5 g of chitosan powder and dissolved in 49.5 ml of water at room temperature for half an hour. 5 5 ml of acetic acid and lightly mix at room temperature for 12 hours. The filter was used to filter impurities on the next day as a 1% chitosan solution, wherein the molecular weight of chitosan-1 was about 510 kDa. The molecular weight of chitosan-2 was about 400 kDa. The resulting solution was filtered through a mesh of ΙΟΟμηι and applied to a glass coverslip (each 15 mm diameter slide coated with ΙΟΟμΙ solution) and allowed to air dry for two days. The chitosan membrane was immersed in a 〇5Ν NaOH solution for 5 minutes, and then rinsed with distilled deionized water over a large area until the pH of the water near the film reached a neutral state. Finally, the chitosan film was sufficiently dried. 1.2 Extraction and culture of rat brain neural stem cells The neural stem cells were isolated from the brain part of the gene-transforming mouse containing the promoter F1B-fluorescent green protein (F1B-GFP) gene. The two-month-old mouse was smashed throughout the brain and lightly ground into smaller pieces to obtain a single cell suspension. The minced cells were seeded in 35-mm cultured blood without supplemental matrix and adhesion factor in DMEM/F-12 medium (Dulbecco, s modified Eagle, s medium and Ham's F-12, constructed in Giboco, USA) 1 :1 The culture medium contains feta bovine serum (FBS) (purchased from Gibco, USA). After two days, nearly 10-20 cells per cell were subjected to cell division. After trypsin treatment, concentrate them and continue to culture for 2-3 days. A stable cell line was further selected with 200 pg/ml of glycoside antibiotic geneticin (G4l8, purchased from Gibco). The GFP-positive mouse brain cells were repeatedly purified by flow cytometry (FACS Aria, purchased from BD Biosciences) to a purity of 95% or more. 1.3 Morphological analysis and differentiation of neural stem cells/neural precursor cells into chitosan membranes Before the neural stem cells were implanted into the culture material, the chitosan membrane on the glass coverslip was immersed in 75% ethanol, and then Phosphate buffered saline (PBS), washed, and placed in each well of a 24-well culture plate. Neural stem cells were implanted at a density of 5 x 1 〇 4 cells per well. Add 10% fetal bovine clear (purchased from Gibco, USA), 12 201219572 40 (^g/ml glycobiotic antibiotic (G418) and streptomycin-penicillin (lOOU/ml) as culture medium in DMEM/F-12 medium. Incubate the culture medium twice at a temperature of 37 C ' 5 ° / ° CO;? humidification incubator; and add tissue culture polystyrene surface (TCPS) without growth factor Gelatin was used as a control group, and the results are shown in the first and second figures.

第一圖顯示神經幹細胞培養於TCPS和明膠上三天的形態,在 TCPS和明膠上無觀察到任何細胞聚集,且細胞貼於TCpS和明移。另 一方面,培養於幾丁聚醣薄膜上的細胞在丨_2天開始聚集,最終聚集為 球狀,剛開始24小時,大部分的細胞形狀為圓形;48小時内多數細胞 聚集形成球體。於幾丁聚膽_丨上球體的數量和大小皆大致比幾丁聚酷_2 還要大(如第二圖所示)。 為痛認本發明實施例所產生之球體為三度空間的立體球體而不只 是聚集,由第三_掃描式電子顯微影像,球體_視圖可清楚顯示 其三度結構,而由絲·顯示細大小縣_增加,可達約獅叫。 另外’第四至六圖則顯示神經幹細胞的分化程度。神經幹細胞的營 光強度’有綠色螢細現表示未分彳卜綠色縣在15天之後開始消退, 但仍然清晰(如第四圖6d所示)。在15天時,—些細胞開始從球内移出, 因此’神經幹細猶體的大小_目錄速,祕㈣細胞未顯現任 何,’彔色螢光。球體在丨5天後螢光消沒除了顯示細胞的移出外,球體内 的細胞也已經分化。 在免疫螢光染色試驗±,神轉細胞的標示蛋白培養於財聚骑·i =表不第五圖所示㈣in)和第六圖所攀她.)。發現球體在Μ天 查=強U顯不具有nestm陽性’顯示球體的細胞可維持神鱗細胞狀態 in;祕的顯示在培養時間增加時些微降低。另-方面,整個 [S] f膜上的表現皆低。此結果顯示神經幹細胞培養於幾丁聚醣 薄膜上可為-維持這些細胞自我更新能力和幹性㈣的方法或 13 201219572 用於自細胞群中純化神經幹細胞。 1.4幾丁聚醣和組織培養板(TCPS)之去乙醯度、表面電位,以及水接觸 角值列於表1。 表1不同的幾丁聚醣(幾丁聚醣_1 (CS—i)和幾丁聚醣_2 (cs_2))和組織培 養板(TCPS)特性比較⑻去乙醯度(b)表面電位,和(c)表面水 接觸角。 材料 去乙酿度 表面電位(mV) 表面水接觸角(°) CS-1 77.7% -3·47±0.21 87.0 土 2_08 CS-2 86.0% -1.97± 0.15 74.2±3.67 TCPS N.A. 64.9土 4.57 幾丁聚醣-1、幾丁聚醣_2的去乙醯度分別約為777%、860%。幾 丁聚醣去乙醯度值越高,表面水接觸角越低,親水性越高,即親水性The first panel shows the morphology of neural stem cells cultured on TCPS and gelatin for three days. No cell aggregation was observed on TCPS and gelatin, and the cells were attached to TCpS and Ming. On the other hand, the cells cultured on the chitosan film began to aggregate on day 丨_2, and eventually aggregated into a globular shape. At the beginning of 24 hours, most of the cells were round in shape; most cells aggregated to form spheres within 48 hours. . The number and size of the spheres on the chitosan _ 丨 大致 are roughly larger than those of the diced _2 (as shown in the second figure). In order to recognize that the sphere produced by the embodiment of the present invention is a three-dimensional space of a three-dimensional sphere instead of just gathering, the third-scanned electron microscopic image, the sphere_view can clearly show the third-degree structure, and the silk display The size of the county is increased, up to about the lion. In addition, the fourth to sixth graphs show the degree of differentiation of neural stem cells. The light intensity of the neural stem cells' has a green fluorescing color, which indicates that the green county began to subside after 15 days, but it is still clear (as shown in the fourth figure 6d). At 15 days, some of the cells began to move out of the sphere, so the size of the neural stems and the size of the corpuscles, the secret (4) cells did not show any, 'black fluorescent. Fluorescence elimination of the sphere after 5 days of sputum In addition to showing the removal of cells, the cells in the sphere have also differentiated. In the immunofluorescence staining test ±, the labeled protein of the god transfected cell cultured in the Cai Ju riding · i = the table shown in the fifth figure (four) in) and the sixth figure climbed her.). It was found that the sphere was in the sky. The strong U showed no nestm positive. The cells showing the sphere maintained the state of the squamous cells. The secret showed a slight decrease when the culture time increased. On the other hand, the performance on the entire [S] f film is low. This result shows that neural stem cells cultured on chitosan membranes can be used to maintain these cells' self-renewal ability and dryness (IV) or 13 201219572 for purification of neural stem cells from cell populations. 1.4 Deacetylation, surface potential, and water contact angle values of chitosan and tissue culture plates (TCPS) are listed in Table 1. Table 1 Comparison of characteristics of different chitosan (chitosan-1 (CS-i) and chitosan-2 (cs_2)) and tissue culture plates (TCPS) (8) de-acetylation degree (b) surface potential , and (c) surface water contact angle. Material to B-degree surface potential (mV) Surface water contact angle (°) CS-1 77.7% -3·47±0.21 87.0 Soil 2_08 CS-2 86.0% -1.97± 0.15 74.2±3.67 TCPS NA 64.9 Soil 4.57 Chitin The deacetylation degree of glycan-1 and chitosan-2 was about 777% and 860%, respectively. The higher the degree of chitosan deacetylation, the lower the surface water contact angle, the higher the hydrophilicity, ie the hydrophilicity.

幾丁聚醣·2大於幾丁㈣卜而兩者幾丁騎表面親水性皆高於 TCPS,因細胞在親水性高的基質中較容易貼附,神經幹細胞貼附於 TCPS上比幾丁聚醣上來得好。而且,神經幹細胞在幾丁聚醣上的貼Chitosan·2 is larger than several dicans (4), and both surfaces are more hydrophilic than TCPS, because cells are easier to attach in a matrix with high hydrophilicity, and neural stem cells are attached to TCPS. The sugar is coming up well. Moreover, the attachment of neural stem cells to chitosan

附比幾丁聚ϋ_1要好,且在幾丁聚醋]上球體形成時間延遲。幾丁聚 膽的去乙ϋ度提高,氨基群和分子内的氫鍵會增加,可能造成表面變 硬和強結晶性,亦與我們的結果一致。幾丁騎_丨與幾丁聚醣_2的表 面電位皆為負值’但數值接近中性,表面電性較負之表面,在本實施 例的結果中’神經幹細胞並沒有_得很好而呈現聚⑽狀況。幾丁 聚膽-1的表面硬度(壓痕深度約5〇nm)近似於内部(壓痕深度.啊。 另方面,幾丁聚醣-2之表面硬度高於内部且亦高於幾丁聚醣],幾丁 f醣_2較幾丁聚醋q粗糙且表面上更加密集的晶體結構。因更硬和結 晶性更高的表面,神經幹細胞可能貼附於幾丁聚骑_2比幾丁聚聽一i更 好且形成的球體較小。 14 201219572 實施例2 以二種褐藻酸鹽薄膜培養成體神經幹細胞/神經前驅細胞、脂肪幹細胞 2.1褐藻酸鹽薄膜製備 利用兩種褐藻酸鹽製備薄膜,包括較低Μ/G比(β-D-mannuronic acid/a-L-guluronic acid ratio)的褐藻酸鹽 A#1 (M/G ratio=0.5 ’ 分子量 110,000,購於Hayashi,Japan)和較高Μ/G比的褐藻酸鹽A#2 (M/G ratio=1.59,分子量 12,000 - 80,000, Sigma, USA)。褐藻酸鹽 A#1 及 A#2 先分別溶於9mg/ml氣化鈉溶液使溶液濃度為40mg/ml。調整溶液pH φ 值至7,以高壓滅菌(125°C以及1.5atm)30分鐘後加入2-[4-(2-羥乙基) 0辰嗓-1 -基]乙續酸(2-[4-(2-hydroxyethyl)piperazin_ 1 -yl] ethanesulfonic acid ’購於HEPES,Invitrogen)維持與人體相同的酸鹼值。本發明實施例 使用的二種褐藻酸鹽皆可製作成平滑或是有皺褶的膜。褐藻酸鹽薄膜 係在每孔加入400μ1褐藻酸鹽至24孔培養板(購於Coming, USA),經 層流風乾60分鐘再沿孔緣緩慢滴入102mM氯化鈣製備。 2·2大鼠脂肪幹細胞(rADASs)之萃取及培養 從大鼠(Spraque-Dawley rate,SD rate)皮下取得脂肪組織,使用構酸 • 鹽緩衝液清洗,剪成小碎塊,第一次離心(1500 rpm,5 mins)。將上層 脂肪倒入新的離心管和加入少許構酸鹽緩衝液,再盡量剪小塊,進行 第二次離心(1500 rpm,5 mins)。取上層脂肪,同時配製消化液:1 mg/mi 第一型膠原蛋白梅(collagenase type I ’購於Sigma)/HBSS溶液(HBSS緩 衝溶液配製如表4)。 表4HBSS緩衝溶液成分 成份 濃度(g/1) NaHC03 0.35 [S1 15 201219572 KC1 0.4 KH2P〇4 0.06 NaCl 8 Na2HP04 * 7H2〇 0.09 CaCl2 0.14 MgCl2 · 6H2〇 0.1 MgS04 * 7H2〇 0.098The ratio is better than that of the chitosan _1, and the spheroid formation time delay on the diced vinegar. The degree of deacetylation of chitosan is increased, and the hydrogen bond in the amino group and the molecule is increased, which may cause surface hardening and strong crystallinity, which is also consistent with our results. The surface potentials of chitin and chitosan-2 are both negative 'but the value is close to neutral, and the surface is more negative. In the results of this example, 'the neural stem cells are not very good. And the poly (10) situation is presented. The surface hardness of the chitosan-1 (indentation depth is about 5〇nm) is similar to the inside (indentation depth. Ah. On the other hand, the surface hardness of chitosan-2 is higher than the internal and higher than the chitin Sugar], chitin f-glucose _2 is coarser and more densely crystallized on the surface. Due to the harder and more crystalline surface, the neural stem cells may be attached to a few squares. Ding Juyiyiyi is better and the formed sphere is smaller. 14 201219572 Example 2 Culture of adult neural stem cells/nerve precursor cells, adipose stem cells 2.1 alginate film with two alginate films. Preparation of two alginates Films were prepared, including alginate A#1 (M/G ratio=0.5 'molecular weight 110,000, purchased from Hayashi, Japan) and lower than the β-D-mannuronic acid/a-galuronic acid ratio. Sorghum/G ratio alginate A#2 (M/G ratio=1.59, molecular weight 12,000 - 80,000, Sigma, USA). Alginate A#1 and A#2 were first dissolved in 9 mg/ml sodium sulphate, respectively. The solution was brought to a solution concentration of 40 mg/ml. The pH value of the solution was adjusted to 7, and after autoclaving (125 ° C and 1.5 atm) for 30 minutes, 2-[4-(2-hydroxyethyl) 0 was added. 2-[4-(2-hydroxyethyl)piperazin_ 1 -yl] ethanesulfonic acid 'purchased from HEPES, Invitrogen) maintains the same pH value as the human body. Both alginate can be made into a smooth or wrinkled film. The alginate film is added with 400 μl alginate per well to a 24-well culture plate (purchased from Coming, USA) and air-dried for 60 minutes. Then, 102 mM calcium chloride was slowly added dropwise along the edge of the well. 2.2 Extraction and culture of rat adipose stem cells (rADASs) Adipose tissue was obtained subcutaneously from rats (Spraque-Dawley rate, SD rate), using acid buffering Wash the liquid, cut into small pieces, centrifuge for the first time (1500 rpm, 5 mins). Pour the upper layer of fat into a new centrifuge tube and add a little acid buffer, then cut the small pieces as much as possible for a second centrifugation. (1500 rpm, 5 mins). Take the upper layer of fat and prepare the digestive juice: 1 mg/mi collagen type I (collagenase type I 'purchased in Sigma) / HBSS solution (HBSS buffer solution is prepared as shown in Table 4). 4HBSS buffer solution component concentration (g/1) NaHC03 0.35 [S1 15 201219572 KC1 0.4 KH2P 4 0.06 NaCl 8 Na2HP04 * 7H2〇 0.09 CaCl2 0.14 MgCl2 · 6H2〇 0.1 MgS04 * 7H2〇 0.098

將脂肪與上述消化液混合’放入細胞培養箱震盪(100 rpm,1小 時)。第三次離心(15〇〇rpm,10分鐘)。使用70m細胞篩(購於Falc〇n, BD Bioscience)過滤細胞液’第四次離心(1500 rpm,5 mins)。將上面 的油層吸走,後加入培養液,放入75T-flask培養皿(購於Falcori,BD Bioscience)。隔天細胞貼附培養材料’將上清液抽出,加入新的培養液。 培養至脂肪細胞8分滿後以0.25%胰蛋白酶/乙二胺四乙酸(購於 Gibco)繼代細胞,細胞密度為50000cells/T-flask。 2.3神經幹細胞/神經前驅細胞於褐藻酸鹽薄膜之形態分析與分化為神 經細胞的情形 鼠腦神經幹細胞/神經前驅細胞萃取步驟如實施例1所述。取得之 細胞培養於2D褐藻酸鹽膜上’ NSPCs植入含有核藻膠的24孔培養板 中(2ml培養液中植入2·5χ104個細胞)。每隔一天更換一半的培養液。 12-24小時後發現NSPCs在褐藻酸鹽膜上聚集,三天後,發現褐藻 酸鹽膜上的細胞團無一致的大小(第七圖)。 在分化的表現上,NSPCs培養於2D褐藻酸鹽膜上形成球體時, 能表現出神經細胞與神經膠細胞的基因;而培養於TCPS上,呈現類纖 維形態的NSPCs卻無法表現神經細胞與神經膠細胞的基因(見第八圖)。 【S] 16 201219572 脂肪幹細ι神',丄幹細皰培養μ天在A#1及A#2上成球的大小如 表所不14天時已55體形成,且球體大小與28天時相似): 植入數量: 5χ104/孔 神經幹細胞 脂肪幹細胞 於ΑΜΛ良否 聚為球狀 是 是 於Α#2是否 I务球狀 是 是 A#1上球體 之直徑(mm) 138.73土 37.04 192.16土 27.94 A#2上球體 之直徑(mm) 121.10土 36.90 141.25士 31.84 實施例3Mix the fat with the above digestive juices and place in a cell culture incubator (100 rpm, 1 hour). The third centrifugation (15 rpm, 10 minutes). The cell fluid was filtered using a 70 m cell sieve (purchased from Falc〇n, BD Bioscience) for a fourth centrifugation (1500 rpm, 5 mins). The above oil layer was aspirated, and then the culture solution was added and placed in a 75T-flask dish (purchased from Falcori, BD Bioscience). The cells were attached to the culture material every other day. The supernatant was withdrawn and a new culture solution was added. After the cells were cultured to 8 minutes, the cells were subcultured with 0.25% trypsin/ethylenediaminetetraacetic acid (purchased from Gibco) at a cell density of 50,000 cells/T-flask. 2.3 Morphological analysis and differentiation of neural stem cells/neural precursor cells into alginate membranes The condition of mouse brain neural stem cells/neural precursor cell extraction was as described in Example 1. The obtained cells were cultured on a 2D alginate membrane. The NSPCs were implanted in a 24-well culture plate containing cyanobacterial gel (2,5χ104 cells were implanted in 2 ml of culture medium). Replace half of the culture medium every other day. After 12-24 hours, NSPCs were found to accumulate on the alginate membrane. After three days, the cell clusters on the alginate membrane were found to have no uniform size (Fig. 7). In the expression of differentiation, NSPCs can express the genes of nerve cells and glial cells when they are formed on 2D alginate membranes. However, NSPCs which are cultured on TCPS and exhibit fiber-like morphology cannot express nerve cells and nerves. Glue cell genes (see Figure 8). [S] 16 201219572 Fat dry fine 神神', dry blister culture μ day The size of the ball on A#1 and A#2 is 55 bodies formed when the table is not 14 days old, and the sphere size is 28 days. Time is similar): Number of implants: 5χ104/well Neural stem cell Adipose-derived stem cells in the ΑΜΛ 否 否 聚 是 是 是 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 138 138 138 138 27.94 A#2 upper sphere diameter (mm) 121.10 soil 36.90 141.25 ± 31.84 Example 3

以二種分子量幾τ驗_以及_素結合功腿域·rgd貼附序列 (CBD-RGD)改質之幾丁聚轉膜培養麟幹細胞 3.1二種分子量的幾丁聚醣薄膜製備 本實&例係使用分子量不同於前述實施例的幾丁聚醋_3(講於 Kiotec),分子量約為170kDa,及幾丁聚醣_1(購於Fkika),分子量約為 510 kDa #取〇.5g幾丁聚畴粉末溶入於49 5mi二次水,室溫下攪拌 半小時後加人0.5m丨乙酸繼續娜一天。隔天使麟網過赫質即為 1%幾丁聚醣溶液。 表3二種幾丁聚酶的去乙醒度與分子量 去乙醯度 分子量 幾丁聚醣-3 97% 170kDa 幾丁聚醣-1 77.7% 510kDa 取1%幾丁聚醣溶液2〇〇μ1均句滴入1.5cm圓形玻片,在常溫下 自然烘乾1-2天;確定膜乾之後,加入〇·5Ν NaOH蓋過玻片5分鐘, 之後用二次水清洗3次後,繼續泡在二次水至隔天;隔天把二次水倒 掉’在室溫下自然陰乾存留的二次水後,即為幾丁聚醣_3及幾丁聚醣·i >專膜。另外並以未加生長因子的聚苯乙烯組織培養板(tjssue cuIture [ y 17 201219572 polystyrene surface, TCPS)作為控制組之一。 另一對照組為聚乙烯醇(PVA)薄膜,因有文獻表示牙胚細胞在pVA 膜上,細胞會聚集可行成細胞球幫助硬骨分化;其製備則是秤取2.5g聚 乙烯醇(Poly vinyl alcoh〇1,PVA ’ 購於 sigma,H〇t water s〇lubk)粉末溶於 50ml 一-人水,利用向溫高壓滅菌爸使之溶解後,溫度降至常溫即為5% 聚乙烯醇溶液。取5〇/〇聚乙烯醇溶液150μ1均勻滴入1.5 cm圓形玻片, 放置60 °C烘箱下一天即為聚乙烯醇膜。 3.2以纖維素結合功能區域_RGD貼附序列(CBD_RGD)改質之幾丁聚 醣-1的薄膜製備 纖維素結合功能區域-RGD貼附序列(CBD-RGD)為中興大學陳震 漢教授所k供,來源為真菌Tric〇derma konigii的纖維水解酶 cellulobiohydrolase I (CBHI)的基因。CBHI 的 N 端有一段 36 個胺基酸 大小的cellulose binding domain(CBD),利用聚合酵素連鎖反應的方法 修改的第五個胺基酸的密瑪,由原來的tyr〇Sin改成了 trypt〇phan,藉以 提高CBD對纖維素的親和力,同時在CBD基因的3端加入一段PT linker及一段rgd序列基因。RGD是細胞貼壁因子(Fibronectin)中促進 細胞貼附的最小功能位,纖維素結合功能區域_RGD貼附序列 (CBD-RGD)具有如SEQ ID N0:1胺基酸序列,因CBD-RGD有很高的 分子2: (25 KDa),只需利用庫倫引力,便形成一種可以促進細胞貼附 於纖維素上的雙功能蛋白質。 本發明實施例將幾丁聚醣_1形成的薄膜結合CBD_RGD,將該薄膜 泡於75%酒精3小時後,使用磷酸鹽緩衝液清洗兩次,放置半小時等 幾丁聚醣-1的薄膜乾;將CBD-RGDGpg^Oy)均勻滴在幾丁聚醣_丨的 薄膜上(4pgCBD-RGDA.77 cm2) ’等1-2小時CBD-RGD乾後,用磷酸 鹽緩衝液清洗一次即為以CBD-RGD改質之幾丁聚醣-1的薄膜。 201219572 3·3大鼠脂肪幹細胞(rADASs)之萃取及培養 大鼠脂肪幹細胞(rADASs)之萃取及培養如實施例2。 3.4脂肪幹細胞在三種幾丁聚醣薄膜之形態分析與分化為心肌細胞的 情形 本實施例分為兩部份,第一部分為比較組織培養板(T)、聚乙烯醇 (P)、幾丁聚醣3(CS3)和幾丁聚醣1(CS1)。將T,P,CS3和CS1薄膜 以75%酒精泡3小時,以構酸鹽緩衝液潤洗後,放入24孔培養板内; 使用0.25%胰蛋白酶(購於Gibco)將大鼠脂肪幹細胞(實驗室用細胞代 • 數為2-6代)打下’收集在培養液内,每孔放入5xi〇4細胞液後,搖晃 培養板,使細胞均勻分散,再放入細胞培養箱内培養。 5-azacytidine (5-aza)是DNA去甲基化的化合物’據研究顯示’藉 著5-aza不規則地去甲基化’會誘導細胞成為心肌細胞,故在第四天換 成含有lOMSaza (5-azacytidine,Sigma)的培養液,實驗組別分為有添 加 5-aza (w 5-aza)與無添加 5-aza(w/o 5-aza)的組別,所以 w/〇 5-aza 的組 別,依舊添加原本的培養液。第五天,將培養液吸出,再次換成不含 5-aza的培養液,繼續培養1星期後(共u天),利用反轉錄聚合酶連鎖 φ 反應(Reverse transcriptionpolymerase chain reaction,RT-PCR),比較心 肌分化的能力’結果如表5與第九、十圖所示。 第二部分為比較T、CS1與CS1結合CBD-RGD (CS1R)的心肌分 化月b力。第一部分與苐一部分的貫驗條件一致,實驗組改為τ,CS1, CS1R’由RT-PCR和免疫螢光染色實驗分析分化心肌能力,結果如表5 與第九、十圖所示。 表5脂肪幹細胞(rADASs)在不同材料上形成的細胞球大小 第1天 第3天 第11天 [S] 19 201219572Preparation of two kinds of molecular weight chitosan films by using two kinds of molecular weights, τ and _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ The system uses a molecular weight different from the above-mentioned examples of chitosan _3 (described in Kiotec), molecular weight of about 170kDa, and chitosan_1 (purchased from Fkika), molecular weight of about 510 kDa #取〇. 5 g of chitin polydomain powder was dissolved in 49 5mi of secondary water, stirred at room temperature for half an hour and then added with 0.5 m of acetic acid to continue for one day. It is a 1% chitosan solution. Table 3 Deacetylation of two kinds of chitinases and molecular weight Deacetylation degree molecular weight chitosan-3 97% 170kDa chitosan-1 77.7% 510kDa 1% chitosan solution 2〇〇μ1 Dilute into a 1.5cm round slide and dry it naturally for 1-2 days at room temperature. After confirming the film dry, cover the slide with 〇·5Ν NaOH for 5 minutes, then wash it with secondary water for 3 times, then continue. Soak in the secondary water to the next day; the next day, the second water is poured off. After the secondary water remaining naturally at room temperature, it is chitosan _3 and chitosan·i > . In addition, a growth factor-free polystyrene tissue culture plate (tjssue cuIture [y 17 201219572 polystyrene surface, TCPS) was used as one of the control groups. The other control group is a polyvinyl alcohol (PVA) film. Because the literature indicates that the tooth germ cells are on the pVA membrane, the cells can aggregate into cell spheres to help the hard bone differentiation; the preparation is to weigh 2.5 g of polyvinyl alcohol (Poly vinyl). Alcoh〇1, PVA 'purchased from sigma, H〇t water s〇lubk) powder dissolved in 50ml of 1-personal water, after dissolving it by warming and autoclaving, the temperature is reduced to 5% at room temperature. . 150 μl of a 5 〇 / 〇 polyvinyl alcohol solution was evenly dropped into a 1.5 cm circular slide, and placed in a 60 ° C oven for one day to form a polyvinyl alcohol film. 3.2 Preparation of cellulose-binding functional region--GRD-attached sequence (CBD-RGD) with a cellulose-binding functional region _RGD attachment sequence (CBD_RGD) modified by chitosan-1 (CBD-RGD) for Professor Chen Zhenhan of Zhongxing University The gene is the gene of the cellulolytic enzyme cellulobiohydrolase I (CBHI) of the fungus Tric〇derma konigii. At the N-terminus of CBHI, there is a 36 amino acid-sized cellulose binding domain (CBD). The fifth amino acid modified by the polymerization enzyme chain reaction method was changed from the original tyr〇Sin to trypt〇. Phan, in order to increase the affinity of CBD for cellulose, and add a PT linker and a rgd sequence gene at the 3th end of the CBD gene. RGD is the smallest functional site in cell adhesion factor (Fibronectin) that promotes cell attachment. The cellulose-binding functional region _RGD attachment sequence (CBD-RGD) has an amino acid sequence as SEQ ID NO: 1 due to CBD-RGD. There is a very high molecular 2: (25 KDa), using only Coulomb gravity, a bifunctional protein that promotes cell attachment to cellulose. In the embodiment of the present invention, the film formed by chitosan-1 is combined with CBD_RGD, and the film is soaked in 75% alcohol for 3 hours, and then washed twice with phosphate buffer solution, and the film of chitosan-1 is placed for half an hour. Dry; uniformly deposit CBD-RGDGpg^Oy) on the film of chitosan 丨 (4pgCBD-RGDA.77 cm2) ' After 1-2 hours of CBD-RGD drying, wash once with phosphate buffer A film of chitosan-1 modified with CBD-RGD. 201219572 3.3 Extraction and culture of rat adipose stem cells (rADASs) The extraction and culture of rat adipose stem cells (rADASs) were as in Example 2. 3.4 Amorphous analysis of adipose-derived stem cells in three chitosan films and differentiation into cardiomyocytes This example is divided into two parts. The first part is to compare tissue culture plates (T), polyvinyl alcohol (P), chitosan. Sugar 3 (CS3) and chitosan 1 (CS1). The T, P, CS3 and CS1 films were soaked in 75% alcohol for 3 hours, rinsed with the acid buffer, and placed in a 24-well culture plate; rat adipose-derived stem cells were prepared using 0.25% trypsin (purchased from Gibco). (Laboratory cell generation number: 2-6 generations) Put down 'collected in the culture solution, put 5xi〇4 cell solution in each well, shake the plate, evenly disperse the cells, and then put them into the cell culture incubator. . 5-azacytidine (5-aza) is a compound that demethylates DNA. According to research, 'demethylation by 5-aza irregularly' induces cells to become cardiomyocytes, so it is replaced with lOMSaza on the fourth day. The culture medium of (5-azacytidine, Sigma) was divided into the group with 5-aza (w 5-aza) and 5-aza (w/o 5-aza), so w/〇5 In the group of -aza, the original culture solution is still added. On the fifth day, the culture solution was aspirated, replaced with a 5-aza-free medium, and cultured for 1 week (total u days) using reverse transcription polymerase chain reaction (RT-PCR). The results of comparing the ability of myocardial differentiation are shown in Table 5 and ninth and tenth. The second part is to compare the myocardial differentiation monthly b force of T, CS1 and CS1 combined with CBD-RGD (CS1R). The first part was consistent with the experimental conditions of the sputum. The experimental group was changed to τ, CS1, and CS1R'. The ability to differentiate myocardium was analyzed by RT-PCR and immunofluorescence staining. The results are shown in Table 5 and Figure IX and Figure 10. Table 5 Cell size of adipose stem cells (rADASs) formed on different materials Day 1 Day 3 Day 11 [S] 19 201219572

球趙大小(μιη) 5-aza - - + T X X X X P 350土50 400士100 X X CS3 35±15 70±60 70±60 30±20 CS1 25 士 15 55 士 45 55±45 55±45 CS1R X 175±90 140±65 160±75 T: TCPS ; P: PVA ; CS3: Chitosanl ; CSl: Chitosanl ; CS1R: Chitosanl+CBD-RGD. 無添加5-aza ; +:添加5-aza ; X:無細胞球.Ball size (μιη) 5-aza - - + TXXXXP 350 soil 50 400 士 100 XX CS3 35±15 70±60 70±60 30±20 CS1 25 士15 55 士45 55±45 55±45 CS1R X 175± 90 140±65 160±75 T: TCPS; P: PVA; CS3: Chitosanl; CSl: Chitosanl; CS1R: Chitosanl+CBD-RGD. No added 5-aza; +: Add 5-aza; X: Cell-free sphere.

由表5與第九、十圖可發現培養於組織培養板之大鼠脂肪幹細胞皆 無法成球’在聚乙稀醇上之大鼠脂肪幹細胞在第三天細胞會聚集最 大’但之後不管有無加5-aza,細胞皆會從聚集的細胞球跑出,所以在 第11天時細胞呈現形態與培養於組織培養板上雷同。在CS3中,第一 天可發現細胞逐漸聚集成細胞球,球大小約35μηι ;第三天,可發現一 顆顆的細胞球,大小比第一天大些,約70μηι ;但繼續培養,會發現較 大顆細胞球會逐漸漂走,在第11天發現CS3㈠比CS3(+)的細胞球較 小顆。在CS1中’第一天也可發現細胞逐漸聚集成細胞球,球大小約 25μπι;第三天’可發現一顆顆的細胞球,大小比第一天大些,約55μηι ; 雖然CS1所形成的球比CS3形成的小要小,但球就不易漂走;CSI(-) 和CS1(+)在第11天的細胞球都約55μηι。在CS1R中,第一天發現細 胞未成球’細胞攤開貼在材料上’與TCPS相似,但有逐漸聚集的趨勢; 第三天’可發現一顆顆大的細胞球’最大顆有達到250μτη ; CS1R上 形成的球都很大顆’但卻幾乎不會漂走;在第11天,CS1R所形成細 胞球比CS3和CS1大ΙΟΡμηι以上。在第η天,會發現cs3、CS1、 20 201219572 CS1R細胞所聚集的球,有些細胞會跑出細胞球,未加$韻的組別比 有加5-aza的組別,細胞跑出細胞球的趨勢更盛。 口此第。卩刀的實驗結果為CS1薄膜最佳,細胞球越大分化效 果越好,但隱$集的大球會再跑出去貼回材料上而⑶留不住大 球’而使剩下的細胞球比CS1要小,所以分化效果較CS1差。 比較第一部分的實驗結果,脂肪幹細胞轉換為心肌細胞在材料 PVA、CS3、CS1雜的基因表現±,由細轉錄因子的基因 來看’ CS1 (+)和CS1㈠比其他組有更好的表現;而後期心肌蛋白的基 _ 因α-MHC,CS1㈩有最好的表現。故第二部份的實驗以cbd_咖改 質CS1的CS1R及CS1為主。 第二部分的實驗在第三天細胞會逐漸聚集成球’細胞球大小比 CS3和CS1大很多,卻不會像⑶形成的大球容易飄走影塑分化。 從實驗中看出,⑶R⑴和CS1R㈠在分化到第u天時,球的大小都 在155邮左右,但添加5_aza的cslR(+)分化能力較佳且與從細胞球 跑出的細胞寡;以RT-PCR分析驗證,⑶則在GATM、與It can be seen from Table 5, ninth and tenth that the rat adipose stem cells cultured in the tissue culture plate cannot be globulated. 'The rat adipose stem cells on the polyethylene glycol will aggregate the most on the third day', but then whether or not there is When 5-aza was added, the cells all ran out of the aggregated cell sphere, so on the 11th day, the morphology of the cells was similar to that of the cultured tissue culture plate. In CS3, on the first day, cells can be found to gradually aggregate into cell spheres with a size of about 35μηι. On the third day, a single cell sphere can be found, which is larger than the first day, about 70μηι; It was found that the larger cell ball gradually drifted away, and on the 11th day, the CS3 (1) cell was smaller than the CS3 (+) cell. In CS1, the cells can be found to gradually aggregate into cell spheres on the first day. The size of the sphere is about 25μπι; on the third day, a single cell sphere can be found, which is larger than the first day, about 55μηι; although CS1 is formed. The ball is smaller than the CS3, but the ball is not easy to float; CSI (-) and CS1 (+) on the 11th day are about 55μηι. In CS1R, on the first day, the cells were found to be unsphered. 'The cells spread out on the material' are similar to TCPS, but there is a tendency to gradually aggregate. On the third day, 'a large cell ball can be found' with a maximum of 250μτη. The balls formed on the CS1R are large but 'nearly drift away; on the 11th day, the cell sphere formed by CS1R is larger than CS3 and CS1. On the ηth day, the balls gathered by the cs3, CS1, and 201219572 CS1R cells will be found. Some cells will run out of the cell ball. The group without the rhyme will be out of the cell group with the 5-aza group. The trend is even stronger. This is the first. The experimental result of the sickle is the best for the CS1 film. The bigger the cell sphere, the better the differentiation effect, but the hidden ball will go out and stick back to the material and (3) can't keep the big ball' and leave the remaining cell ball. It is smaller than CS1, so the differentiation effect is worse than CS1. Comparing the results of the first part, the expression of adipose-derived stem cells into cardiomyocytes in the material PVA, CS3, CS1 was ±, and the genes of the fine transcription factors showed that CS1 (+) and CS1 (1) were better than other groups. The base of late myocardial protein has the best performance due to α-MHC and CS1 (10). Therefore, the second part of the experiment is based on CS1R and CS1 of cbd_ coffee modification CS1. In the second part of the experiment, the cells will gradually aggregate into the ball on the third day. The size of the cell sphere is much larger than that of CS3 and CS1, but it is not easy to drift away from the shape of the large ball formed by (3). It can be seen from the experiment that (3) R(1) and CS1R(1), when differentiated to the uth day, the size of the sphere is about 155 post, but the cslR(+) with 5_aza added has better differentiation ability and the cell oligo from the cell ball; RT-PCR analysis verified that (3) is in GATM, and

Tr〇_n ϊ都呈現出比Cs叫)分化能力較好的趨勢,所以有加5. 糾實增加分化絲:球的大小與球的形成也蚊了錢分化效果,Tr〇_n ϊ all show a better tendency than the Cs) differentiation, so there is a plus 5. Correction increases the differentiation of silk: the size of the ball and the formation of the ball also the effect of mosquito differentiation.

csir>csi >tcps。 > J 由免疫染色也可發現’ GATM與都只有在細胞球的地方 表現’單-顆細胞幾乎無螢光表現,跑出細胞球的細胞也無營光表現。 CBD-RGD改質CS4的基因表現第十一圖可看出前期基因⑽从、後 期基因a-MHC Troponin I,分化能力最好為CSR(+),其次為c叫), 所以添加5-aza對於心肌分化是有幫助的。也由此可看出cbdrgd改 質⑶確實比未改質的CS1有更好的分化能力。因此,脂肪幹細胞在 CS1薄膜和CS1R薄膜’在基因表現與免疫化學染色上都有 分化效果。 [S] 21 201219572 另外CBD-RGD改質之生物高分子包括但不限於幾丁聚膽,本發 明提及之生物相容性高分子皆可用CBD_RGD改質以增進成體幹細胞 成球狀。 實施例4 以-種幾丁聚醣膜培養牙酿幹細胞及包皮纖維母細胞 4.1幾丁聚醣膜製備 利用中黏度的幾丁聚_]、去乙醯度777%、平均分子量約為 5職的m幾丁聚_鮮㈣溶於1%乙酸(購於sh_),過滤後 • 塗雜15咖蓋玻片(購於咖如陶。幾丁聚醣薄膜於室溫風乾,以 〇.5二氫氧化也谷液中和幾聽的酸性。再卩二次蒸館水清洗幾丁聚 酿薄膜上錢的氫氧化鈉。再將所有的幾丁聚賴浸於Μ%酒精和照 ^紫外線以制鋪絲。該幾了聚賴最後以磷賴緩衝液清洗掉 f餘的75%酒精。為比較幾丁聚醣的結果,另以去乙醯度86%、分子 勺40〇k〇a的幾丁聚賴(購於犯_)以上述相同方式製備。在本實 &例中以4丁聚醣代表幾丁聚师心),以幾丁雜代表幾丁 聚醣(Sigma>。 _ 4.2人崎崎細胞及人類包麵維雜鮮取和培養 :由健康成人牙財取得人辭缝織。人類牙崎細祕養於含有 最低必須α培養液(α—jyjgM,購於⑽如)力口祕胎牛血清和2%抗生素 抗真菌藥物(2讀_盤尼西林(基底)、2 μ_鏈黴素(基底)和$ n〇g/ml兩性黴素)(購於Gibc〇)的細胞培養瓶(c〇ming)中培養於坑, “ 2的;I。養箱中。每兩天更換基本培養液一次。在人類牙齦幹細胞 旻蓋達60/〇到7〇〇/0時以〇 25〇/〇騰蛋白酶/乙二胺四乙酸溶液(靖於g出c〇) 收取。本實施例使㈣三到七代的牙齦幹細胞。 取彳于健康成人的包皮纖維母細胞(Human foreskin fibroblasts, [s] 22 201219572 HSF)。人類包皮纖維母細胞以含高糖源之DMEM(購於Gibco)添加 10%胎牛血清(購於Gibco),200mM榖氨醯胺(購於Gibco),1%MEM非 必需氨基酸100X溶液(購於Sigma),和1%盤尼西林/鏈黴素(5000 units/mL盤尼西林(基底)和50(%g/mL鏈黴素(基底))培養於細胞培養 瓶中。HSF培養於37°C ’ 5% C02的培養箱中,每兩天更換基本培養液 一次。在人類包皮纖維母細胞覆蓋達80%到90%時以0.25%胰蛋白酶 /乙二胺四乙酸溶液(購於Gibco)收取。本實施例使用第28代的包皮纖 維母細胞(HSF)。 4.3人類牙齦幹細胞於幾丁聚醣薄膜上之形態分析與分化為軟骨細胞 的情形 人類牙齦幹細胞(4><104cells/ml)植入每一置於24孔組織培養板中之 幾丁聚醣膜,每兩天更換培養液一次。 細胞植入後三天,加入軟骨細胞誘導培養液以誘導二種幾丁聚醣膜 和TCPS上人類牙齦幹細胞的軟骨形成。軟骨細胞誘導培養液含有含高 糖源之 DMEM(購於 Gibco)、l〇ng/mi 的 TGF_p3 (Cyt〇Lab/pepr〇Tech, 購於 Rehovot,Israel)、ΙΟ 7 Μ 的 dexamethasome(購於 Sigma)、50pg/ml 的1-抗壞血酸-2-鱗酸(購於Sigma),卿咖1的L-脯氨酸(購於Sigma)、 lOpg/ml的ITS-預混料1〇χ (購於sigma)、1〇%的胎牛血清(購於 Gibco),和2/〇的抗生素-抗真菌劑。人類牙齦幹細胞培養於含誘導培養 液之培養射7天和14天’每兩天更_導培養液—次。人類牙銀幹 細胞培養於幾丁聚醣·1、幾丁聚ϋ·2和TCPS薄膜上植人後三天的形態 見第十二圖。 4.4人類包皮纖維母細胞於幾丁聚聽薄膜上之形態分析與分化為軟骨 細胞的情形 另以相同條件之人類包皮纖維母細胞做為對照組,人類包皮纖維母 [S1 23 201219572 «胞(〇cells/ml)植入每-置於24孔組織培養板中之幾丁聚酷薄膜和 TCPS ’輯以基本生長培魏和軟骨細麟導轉液培養,每兩天更 換培養液—次,人類包皮纖維母細胞培養於幾丁聚聽-1薄膜上植入後 三天的形態見第十二圖。 請參閱第十二圖,培養於幾丁聚醣·i薄膜上之人類包皮纖維母細 胞無球體形成(第十二圖A)。而培養於幾了聚· 細胞树想形成(第十二圖8),此清楚顯示並非所有的細 聚醣-1缚膜上皆會形成球體,因為在本實施例中,本身並不會形成球 體的人斷齦幹細胞卻可於幾丁聚.丨_上形成球體,而人類包皮 » _母細舰未縣。第忙圖D即顯示人·齦幹細祕養於Tcps 上無球體形成的情況。此外,人類牙齦幹細胞培養於不同分子量的幾 丁聚醣薄膜時’形成球的比例也不相同;在第十二圖(b、^,在人類 牙齦幹細胞植入後三天,培養於幾丁聚醣·!薄膜形成之球體比在幾丁 聚醣_2薄膜上來得多。這表示幾丁聚醣]可能較幾丁聚酿J容易誘導 人類牙齦幹細胞球體的形成。 並可進-步參娜十三®’細示人斷轉細胞培養於幾丁聚膽Csir>csi >tcps. > J can also be found by immunostaining. 'GATM and all are only in the cell sphere. 'Single-cells have almost no fluorescence, and cells that run out of the cell sphere have no performance. The gene expression of CBD-RGD modified CS4 can be seen in the eleventh figure. The early gene (10) and the late gene a-MHC Troponin I have the best differentiation ability (CSR(+), followed by c), so add 5-aza. It is helpful for myocardial differentiation. It can also be seen that cbdrgd modification (3) does have better differentiation ability than unmodified CS1. Therefore, adipose-derived stem cells have differentiation effects on both CS1 and CS1R membranes in both gene expression and immunochemical staining. [S] 21 201219572 In addition, CBD-RGD modified biopolymers include, but are not limited to, chitosan. The biocompatible polymers mentioned in the present invention can be modified with CBD_RGD to promote adult stem cells into globular shape. Example 4: Culture of dental stem cells and foreskin fibroblasts with a chitosan membrane 4.1 Chitosan membrane preparation Using a moderate viscosity of _], a deacetylation degree of 777%, an average molecular weight of about 5 m diced poly _ fresh (four) dissolved in 1% acetic acid (purchased in sh_), filtered • coated 15 coffee cover slips (purchased in coffee pottery. Chitosan film dried at room temperature, 〇.5 The dihydric hydroxide also neutralizes the acidity of the liquid. Then the second steaming water washes the sodium hydroxide on the chitosan film. Then immerse all the diced polydamine in the Μ% alcohol and the UV In order to make the silk, the last one is washed with phosphorus leaching buffer to wash off the remaining 75% of the alcohol. For the comparison of chitosan results, another 86% of the deacetylation, molecular spoon 40〇k〇a The chitosan (purchased _) was prepared in the same manner as described above. In the present example, 4 chitosan is used to represent chitosan, and chitosan is used to represent chitosan (Sigma). _ 4.2 People's Sakisaki cell and human surface noodles and fresh-keeping and cultivation: It is obtained from healthy adult teeth. The human tooth paste is secreted in the minimum necessary alpha culture solution (α-jyjgM, purchased from (10) such as Likou secret fetal bovine serum and 2% antibiotic antifungal drugs (2 reads _ penicillin (basal), 2 μ_ streptomycin (basal) and $ n〇g / ml amphotericin) (purchased in Gibb〇 The cell culture flask (c〇ming) is cultured in a pit, "2; I. In the box. Change the basic culture solution once every two days. In human gingival stem cells, cover up to 60/〇 to 7〇〇/0 In the case of 〇25〇/〇 蛋白酶 / 乙 乙 乙 乙 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 Human foreskin fibroblasts, [s] 22 201219572 HSF). Human foreskin fibroblasts were supplemented with 10% fetal bovine serum (purchased from Gibco) in 200 mg of high-sugar source DMEM (purchased from Gibco), purchased from Gibco ), 1% MEM non-essential amino acid 100X solution (purchased in Sigma), and 1% penicillin/streptomycin (5000 units/mL penicillin (basal) and 50 (% g/mL streptomycin (basal)) cultured in cells In the culture flask, HSF was cultured in a 37 ° C '5% C02 incubator, and the basic medium was changed once every two days. When the human foreskin fibroblasts covered 80% to 90%, the value was 0. .25% trypsin/ethylenediaminetetraacetic acid solution (purchased from Gibco). This example uses the 28th generation of foreskin fibroblasts (HSF). 4.3 Morphological analysis of human gingival stem cells on chitosan film In the case of differentiation into chondrocytes, human gingival stem cells (4 >< 104 cells/ml) were implanted into each of the chitosan membranes placed in a 24-well tissue culture plate, and the culture solution was changed once every two days. Three days after cell implantation, chondrocyte-inducing medium was added to induce cartilage formation of human gingival stem cells on both chitosan membranes and TCPS. Chondrocyte-inducing medium contains DMEM (purchased from Gibco) containing high sugar source, TGF_p3 (Cyt〇Lab/pepr〇Tech, purchased from Rehovot, Israel), dex 7 Μ dexamethasome (purchased in Sigma) ), 50 pg/ml of 1-ascorbic acid-2- tartaric acid (purchased in Sigma), L-valine (purchased from Sigma) of Qingca 1 and ITS-premix of lOpg/ml 1 (purchased in Sigma), 1% fetal calf serum (purchased from Gibco), and 2/〇 antibiotic-antimycotic. Human gingival stem cells were cultured in a medium containing the inducing medium for 7 days and 14 days 'every two days. The morphology of human dental silver stem cells cultured on chitosan·1, chitosan-2 and TCPS films for three days after implantation was shown in Fig. 12. 4.4 Morphological analysis and differentiation of human foreskin fibroblasts on chitosan membranes. Human foreskin fibroblasts under the same conditions were used as a control group, human foreskin fibrils [S1 23 201219572 «Cell (〇 Cells/ml) implanted in each of the 24-well tissue culture plates and the TCPS' series with basic growth culture and cartilage sylvestris transfer medium, change the culture solution every two days - times, human The morphology of the foreskin fibroblasts cultured on the chitosan-1 film for three days after implantation is shown in Fig. 12. Referring to Fig. 12, the human foreskin fiber cells cultured on the chitosan·i film are free of spheroid formation (Fig. 12A). However, it has been cultivated in several clusters of cells to form (12th Figure 8), which clearly shows that not all of the chitosan-1 binding membranes will form spheres, because in this embodiment, they do not form themselves. A person with a spheroid breaks a stem cell but can form a sphere on a few scorpions, while a human foreskin» _ mother is not a county. The first busy graph D shows the situation where no one sphere is formed on the Tcps. In addition, when human gingival stem cells are cultured in chitosan films of different molecular weights, the ratio of 'forming spheres is different; in the twelfth map (b, ^, three days after implantation of human gingival stem cells, cultured in a few squares Sugar·! The film formed by the film is much more than that on the chitosan-2 film. This means that chitosan] may induce the formation of human gingival stem cell spheres more easily than the chitosan J. Thirteen® 'detailed human broken cell culture in chitin

d上在植人後12、Μ、16、18、2G ' 22和24小時同—範圍的活細胞 造影。培養於幾T聚醣·1上之人類牙轉細胞於植人後η小時開始形 成球體,24小時後初步戰顧。剛植人時人類牙崎細胞貼附於幾 丁聚_-1上呈現類纖維的形態。但隨著培養時間的增加,越來越多的 人類牙齦幹細胞成球,而_於幾m的人類牙齦幹細胞越 來越少。 另外,參閱第十四圖顯示培養於幾丁聚膽和Tcps,有無軟骨講導 培養液在植人後G到3天、加人軟骨料培養液後Q、卜2、7和14 天之人類牙齦幹細胞形態。人類牙酿幹細胞在整個培養過程中為類纖 維的形態。隨著細胞培養時間增長,人類牙齦幹細胞形成相對越來越 m 24 201219572 大的細胞球體。此外,許多人類牙齦幹細胞看似自細胞球中遷出,形 成細胞團和細胞群。當在添加基本生長培養液之幾丁聚醣薄膜上之 人類牙齦幹細胞細胞球數量隨時間漸增,大約在軟骨誘導後14天(或植 入後17天)看起來似乎有自球體的分泌物。另一方面,培養於tcps之 人類牙齦幹細胞則完全沒有形成球狀。 由前述結果可知,不是所有培養於幾丁聚醣的細胞都會形成球體, 例如人類包皮纖維母細胞,也不是所有類型的幾丁聚醣(例如幾丁聚醣 -1和幾丁聚醣-2)都有相同誘導細胞成球的效果。培養於幾丁聚醣薄膜 上之人類牙齦幹細胞比培養於TCPS之人類牙酿幹細胞有較高的軟骨 • 分化潛能。特別重要的是,培養於無軟骨誘導之幾丁聚醣薄膜的人類 牙齦幹細胞之軟骨細胞分化潛能竟能比培養於有軟骨誘導之TCPS上 人類牙齦幹細胞要高。換句話說,人類牙齦幹細胞之軟骨細胞分化潛 能可因單純培養於本發明幾丁聚醣薄膜上而提升。 在確定本發明人類牙齦幹細胞球具有多潛能性和幹性,係藉由 NANOG和Oct 4兩種幹性標記決定未分化幹細胞的自我更新過程,因 此’ NAN0G和Oct 4常被用來作為區別未分化細胞的標記,〇ct 4特 別用來防止細胞分化。另外,神經脊細胞為一短暫多能和遷移能力的 籲 細胞群。特定兩段神經脊SLUG和SoxlO決定神經脊的規範及分化。 本實施例中,我們發現SLUG、Sox 10、NANOG和Oct 4基因表現在 培養於幾丁聚醣薄膜之人類牙齦幹細胞皆比培養於TCPS之人類牙齦 幹細胞高。這表示只形成於幾丁聚醣上之人類牙齦幹細胞的球體與一 般類纖維形態相比,有較高的神經脊基因表現和幹性基因表現。換句 話說,形成球體的人類牙齦幹細胞與短暫多能、遷移能力且大多數皆 為未分化的細胞相關。另外,在人類牙齦幹細胞球體時似乎在多能、 遷移能力和幹性上有增加。這可在植入後〇到3天人類牙齦幹細胞在 幾丁聚醣薄膜上之球體在SLUG、Sox 10、NANOG和Oct 4基因表現 25 201219572 • 上得到證實。因此,球體的形成幫助維持人類牙齦幹細胞的多潛能性、 遷移能力以及幹性。另外’從活細胞成像中觀察上述人類牙銀幹細胞 在幾丁聚醣上成球形,球形由人類牙齦幹細胞的連續細胞-基質交互作 用和細胞-細胞交互作用導致動態運動而形成。這球體的動態狀態亦證 實從神經脊基因表現指出球體中人類牙齦幹細胞的遷移能力。本研究 中觀察到人類牙齦幹細胞形成的所有形態中,形成球體内的人類牙齦 幹細胞持續進出球體。當人類牙齦幹細胞自球體内遷出,人類牙齦幹 細胞會散出並以類纖維形態附著於幾丁聚醣上。因此,球體形態的人 類牙酿幹細胞仍維持多潛能性和幹性,這是在類纖維形態的人類牙齦 Φ 幹細胞所沒有的。 另外,將骨髓間葉幹細胞(b〇ne marr〇w_derived MSCs)培養於幾丁 聚醣-1膜上,亦會形成球形(見第十五圖)。 實施例5 以歲丁聚st和幾丁雜·翻質酸觀養胎盤、麟幹細胞 5.1幾丁聚酿和幾丁聚酿-透明質酸(HA)薄膜製備 驗胃1粉末分子量為51GkD樣於黯a)雜1%乙酸以取得On the d, live cells were imaged at 12, Μ, 16, 18, 2G '22 and 24 hours in the same range. The human tooth-transplanted cells cultured on several T-glycans 1 began to form spheres at η hours after implantation, and were initially taken after 24 hours. When the human is implanted, the human tooth-stained cells are attached to the form of fibrils on the poly-_-1. However, as the culture time increases, more and more human gingival stem cells become globular, and there are fewer and fewer human gingival stem cells. In addition, refer to Figure 14 for humans cultured in chitosan and Tcps, with or without cartilage-directed culture solution for G to 3 days after implantation, plus human chondrocyte culture solution after Q, Bu 2, 7 and 14 days. Gingival stem cell morphology. Human dental stem cells are in the form of fibrils throughout the culture process. As cell culture time increases, human gingival stem cells form relatively large cell spheres of m 24 201219572. In addition, many human gingival stem cells appear to migrate out of the cell sphere, forming cell clusters and cell populations. When the number of human gingival stem cell spheres on the chitosan film added to the basic growth medium increases with time, it appears that there is a self-spherical secretion about 14 days after cartilage induction (or 17 days after implantation). . On the other hand, human gingival stem cells cultured in tcps did not form a sphere at all. From the foregoing results, it is known that not all cells cultured in chitosan form spheres, such as human foreskin fibroblasts, nor all types of chitosan (eg, chitosan-1 and chitosan-2). ) have the same effect of inducing cells into a ball. Human gingival stem cells cultured on chitosan membranes have higher cartilage differentiation potential than human dental stem cells cultured in TCPS. It is particularly important that the human chondrocyte differentiation potential of the human gingival stem cells cultured without the cartilage-induced chitosan thin film is higher than that of the human gingival stem cells cultured on the chondrocyte-induced TCPS. In other words, the chondrocyte differentiation potential of human gingival stem cells can be enhanced by simply culturing on the chitosan film of the present invention. In determining the pluripotency and dryness of the human gingival stem cell sphere of the present invention, the self-renewal process of undifferentiated stem cells is determined by two dry markers, NANOG and Oct 4, so 'NAN0G and Oct 4 are often used as differences. Markers of differentiated cells, 〇ct 4 are specifically used to prevent cell differentiation. In addition, neural ridge cells are a group of cells that are transiently pluripotent and migratory. Specific two-segment neural ridges SLUG and SoxlO determine the specification and differentiation of neural ridges. In this example, we found that the SLUG, Sox 10, NANOG, and Oct 4 genes exhibited higher levels of human gingival stem cells cultured in chitosan films than human gingival stem cells cultured in TCPS. This means that the spheres of human gingival stem cells formed only on chitosan have higher neurological gene expression and dry gene expression than the general fiber-like morphology. In other words, human gingival stem cells that form spheres are associated with transient pluripotent, migratory, and mostly undifferentiated cells. In addition, there appears to be an increase in pluripotency, migration capacity and dryness in human gingival stem cell spheres. This can be confirmed by the SLUG, Sox 10, NANOG and Oct 4 gene expression on the chitosan film by human gingival stem cells 3 days after implantation. Thus, the formation of spheres helps maintain the pluripotency, migration and dryness of human gingival stem cells. In addition, it has been observed from living cell imaging that the above human dental silver stem cells are spherical on chitosan, and the spherical shape is formed by continuous cell-matrix interaction of human gingival stem cells and cell-cell interaction resulting in dynamic movement. The dynamic state of the sphere also confirms the ability of the neural crest gene to indicate the migration of human gingival stem cells in the sphere. In this study, it was observed that in all forms of human gingival stem cell formation, human gingival stem cells that form spheroids continue to enter and exit the sphere. When human gingival stem cells migrate out of the spheroid, human gingival stem cells will emanate and attach to chitosan in a fibrillar form. Therefore, the human-shaped stem cells in the form of spheres still maintain pluripotency and dryness, which are not found in the fiber-like human gingival Φ stem cells. In addition, bone marrow mesenchymal stem cells (b〇ne marr〇w_derived MSCs) are cultured on the chitosan-1 membrane and also form a sphere (see Figure 15). Example 5 The sample of the stomach 1 powder has a molecular weight of 51 GkD in the form of a small amount of polystyrene and a few butaric acid, a placenta, a stem cell, a chitosan, a chitosan, and a hyaluronic acid (HA) film.黯a) mixed with 1% acetic acid to obtain

二;容劑蒸發後,即為幾丁聚醣膜。每孔加入氫氧化鈉 (〇馬㈣分鐘,再峨鹽緩衝液清洗數次。 城鈉 幾丁聚,,透明質帶正電的幾丁聚_合。 CH0.5 和 CH2.5 ▲的4丁獅透日_»以 C、CH(U、 酸鹽緩衝同透明f酸量的幾丁雜·透日謂酸膜以磷 先5-人以缺未鍵結的透„義後魏。㈣ΚΗ〇 5 [S] 26 201219572 和CH2.5的有效吸收率分別為94%、95%和89%。透明質酸被吸收的 總量依初始添加透明質酸量增加而增加。另外並以未加生長因子的聚 苯乙烯組織培養板(tissue culture polystyrene surface,TCPS)作為對照組。 5.2人類胎盤幹細胞(hPDMSC)之萃取和培養 取健康母體懷孕後期(38-40周)捐贈之胎盤。將胎盤以磷酸鹽緩衝 液清洗幾次然後將之打碎和在37t以〇.25%胰蛋白酶酵素處理約1〇 分鐘。在打碎和酵素處理後,此勻漿培養於DMEM_LG(Dulbecc〇,s Modified Eagle Medium-low glUC0se)(購於 Gibe〇)完全培養基,添加 1〇0/〇 胎牛血清(購於Gibco)、1〇 mg/l盤尼西林·鏈黴素和1〇 mg/〖L_榖胺醯 胺(構於Tedia^細胞培養於37t水氣飽和的空氣,以及州的c〇2。每 週更換培養液兩次。 5.3脂肪幹細胞(hADAS)之萃取和培養 脂肪幹細胞可於脂肪組織中取得。從脂肪組織中以酶萃取出細胞。 先將脂肪組織打碎成數塊再以200 U/ml第一型膠原酶(購於 Sigma-Aldrich)磷酸鹽緩衝液中在37。(:輕拌30分鐘。將勻衆培養於 DMEM-LG(Dulbecco's Modified Eagle Medium-low glucose)(購於 Gibco) 元全培養基中’添加10% (v/v)胎牛血清(購於Gibco)、10 mg/1盤尼 西林-鏈黴素。培養箱維持37°C/5°/〇C02。每週更換培養液兩次。 5.4胎盤幹細胞和脂肪幹細胞於幾丁聚醣和幾丁聚醣_透明質酸薄膜上 的形態分析及分化為軟骨細胞的情形 脂肪幹細胞和胎盤幹細胞(3χ104個細胞)植入每一含基本培養液之 幾丁聚醣膜培養三天後,將培養液更換為軟骨細胞誘導培養液。誘導 培養液為 DMEM-LG,含有 10 ng/ml TGF-p3 (購於 CytoLab/Peprotech, Rehovot,Israel)、0.1 μΜ dexamethasome、50 pg/ml L-ascobate-2-填酸,40 pg/ml L-脯氨酸(Sigma)、1%胰島素-轉鐵因子-硒補充劑(iTS+premix) 27 201219572 ιοοχ (購於sigma)以及m盤尼西林·鏈黴素。誘導培養液每週更換兩 次。另-組(植讀3天)仍域柄魏騎料控制組。 脂肪幹細胞在培養於幾丁聚畴-透明質酸薄膜上i天後,脂肪幹細 胞聚集而成的三維球形成。隨著幾丁聚_上的透师酸增加,形成 的球體越明顯’且數量和大小皆較大。脂肪幹細胞和胎盤幹細胞培養 於tcps、幾丁聚醣、幾丁聚醣·透明_膜上第3天的形態如第十六圖 所示。培養於細上3天後,培養於幾丁雜和幾了練·透明質酸薄 膜之脂肪幹細胞和胎盤幹細胞皆形成雜。不同細胞在這些膜上平均 細胞球的大小列於表6。Second, after the solvent is evaporated, it is a chitosan film. Sodium hydroxide was added to each well (the horse was shaken for four minutes, and then washed several times with the salt buffer. The sodium of the city was agglomerated, and the hyaluronic acid was positively charged. CH0.5 and CH2.5 ▲ of 4 Ding Shi through the day _» by C, CH (U, acid buffer and transparent f acid amount of a few miscellaneous · through the acid membrane to phosphorus first 5 - people to lack of unbonded „ 后 post-wei. (4) ΚΗ有效5 [S] 26 The effective absorption rates of 201219572 and CH2.5 were 94%, 95% and 89%, respectively. The total amount of hyaluronic acid absorbed increased with the increase of the amount of hyaluronic acid added initially. Growth factor polystyrene surface (TCPS) was used as a control group. 5.2 Extraction and culture of human placental stem cells (hPDMSC) The placenta donated by the healthy mother during the late pregnancy (38-40 weeks). The phosphate buffer was washed several times and then broken up and treated with 25% trypsin at 37t for about 1 minute. After shredding and enzyme treatment, the homogenate was cultured in DMEM_LG (Dulbecc〇, s Modified Eagle Medium-low glUC0se) (purchased from Gibe〇) complete medium, add 1〇0/fetal bovine serum (purchased from Gibco), 1〇 Mg/l penicillin·streptomycin and 1〇mg/〖L_Amidoxime (constructed in Tedia^ cells cultured in 37t water-saturated air, and state c〇2. The culture medium was changed twice a week. 5.3 Extraction and culture of adipose stem cells (hADAS) Adipose stem cells can be obtained from adipose tissue. The cells are extracted by enzymatic extraction from adipose tissue. The adipose tissue is first broken into several pieces and then 200 U/ml type I collagenase (purchased) In Sigma-Aldrich) phosphate buffer at 37. (: Mix for 30 minutes. Shame culture in DMEM-LG (Dulbecco's Modified Eagle Medium-low glucose) (purchased from Gibco) in the whole medium 'Add 10% (v/v) fetal bovine serum (purchased from Gibco), 10 mg/1 penicillin-streptomycin. Incubator maintained at 37 ° C / 5 ° / 〇 C02. Change medium twice a week. 5.4 placental stem cells and fat Morphological analysis of stem cells on chitosan and chitosan-hyaluronic acid film and differentiation into chondrocytes. Adipose stem cells and placental stem cells (3χ104 cells) were implanted into each chitosan containing basic culture solution. After three days of membrane culture, the culture medium was replaced with chondrocyte-inducing culture medium. The nutrient solution is DMEM-LG, containing 10 ng/ml TGF-p3 (purchased from CytoLab/Peprotech, Rehovot, Israel), 0.1 μΜ dexamethasome, 50 pg/ml L-ascobate-2-acid, 40 pg/ml L- Proline (Sigma), 1% insulin-transferrin-selenium supplement (iTS+premix) 27 201219572 ιοοχ (purchased from sigma) and m penicillin streptomycin. The induction medium was changed twice a week. The other-group (planted for 3 days) is still in the domain of the Wei riding control group. The adipose stem cells were formed on a chitin polyhedral-hyaluronic acid film for one day, and a three-dimensional sphere formed by aggregation of the fat stem cells was formed. As the osmotic acid on the chitosan increases, the resulting sphere becomes more pronounced' and the number and size are larger. The morphology of adipose stem cells and placental stem cells cultured on tcps, chitosan, chitosan, and transparent membranes on day 3 is as shown in Fig. 16. After 3 days of culture, the adipose stem cells and placental stem cells cultured in a few butts and a few hyaluronic acid membranes were mixed. The average cell size of the different cells on these membranes is listed in Table 6.

*每一平均值為至少2〇個球體直徑之平均*Each average is the average of at least 2 sphere diameters

表6胎盤幹細胞與脂肪幹細胞在不同膜上形成之球體平均大小 TCPS C CH0.1 CH0.5 CH2.5 無球體生 hADAS 成 22±5μιη 30±15μηι 35±15μιη 40±18μιη 無球體生 hPDMC 成 20±7μηι 33±12μηι 45±19μηι 54±25μιη 在確定本發明在培養期間脂肪幹細胞和胎盤幹細胞的幹性標記基 因(Oct4、Sox2和Nanog)的表現。在基本培養液的脂肪幹細胞和胎盤幹 細胞之Oct4、Sox2和Nanog的mRNA表現以即時RT-PCR分析。在第 十七圖顯示脂肪幹細胞培養於不同材料和TCPS對照的〇ct4、8〇χ2和Table 6 Average size of spheres formed by different types of placental stem cells and adipose stem cells on different membranes TCPS C CH0.1 CH0.5 CH2.5 No spheres produced hADAS into 22±5μιη 30±15μηι 35±15μιη 40±18μιη No spheres produced hPDMC into 20 ±7μηι 33±12μηι 45±19μηι 54±25μηη The expression of the dry marker genes (Oct4, Sox2 and Nanog) of the adipose stem cells and placental stem cells of the present invention during the culture was determined. mRNA expression of Oct4, Sox2 and Nanog in adipose stem cells and placental stem cells in basic culture was analyzed by real-time RT-PCR. In Figure 17, it is shown that adipose stem cells are cultured in different materials and TCPS controls of 〇ct4, 8〇χ2 and

Nanog之mRNA表現量化結果。在幾丁聚醣和幾丁聚醣-透明質酸之Nanog mRNA showed quantitative results. In chitosan and chitosan-hyaluronic acid

Oct4、Sox2和Nanog基因表現在第3天增加,然後在第7和第1〇天降 低。在第一天和第三天,這些基因的表現在CH2 5薄膜上為最高 (ρ<0·05)。 大致上,胎盤幹細胞的這些基因可被幾丁聚醣和幾丁聚醣_透明質 、[S] 28 201219572 _上的向上觸可轉七 ^ 矛間。在月曰肪幹細胞中,這些基因的 這此朗物^天的叫麵物樹,CH2·5比其他材料維持 ==果較好。在胎盤幹細胞令,⑽5與The Oct4, Sox2, and Nanog gene expression increased on day 3 and then decreased on day 7 and day 1. On the first and third days, the performance of these genes was highest on the CH2 5 film (ρ < 0.05). In general, these genes in placental stem cells can be converted between chitosan and chitosan-transparent, [S] 28 201219572 _ on the upward touch. In the monthly fat stem cells, these genes are called the surface tree, CH2·5 is better than other materials. In the placenta stem cell order, (10) 5 with

特性表現的效果一樣好。 了、一土 U 脂肪幹細胞和胎盤幹細胞培養於幾丁聚醋和幾丁聚膽_透明質酸 料後7天,以灯撕量倾靴_和胎盤幹細 ,的軟骨細胞基因表現,結果如第十八圖。在形成球體後,軟骨基因The performance of the feature is just as good. , a soil U fat stem cells and placental stem cells were cultured in a few days after the diced vinegar and chitosan _ _ hyaluronic acid materials, with the light torn the boot _ and the placenta dry fine, chondrocyte gene performance, the results such as Eighteenth picture. After forming a sphere, the cartilage gene

、·οχ_9 ' __和eQUagen咖在軟賴導下齡增加(第十 八圖B、D、F),與培養於基本培養液比較(第十八圖a ' c、切。當脂 肪幹細胞培養於有基本培養液之幾y聚醣和幾丁聚私透明質酸時,這 些基因有高度的表現(與TCPS/基本培養液比較)。另一方面當胎盤幹 細胞培養於有基本培養液之幾了騎和幾n透日㈣酸上時這些 基因呈低度表現(與TCPS/基本培養液比較)。培養於有基本培養液的幾 丁聚醣和幾丁騎·透明f酸之脂崎細胞的軟纽倾力比胎盤幹細 =要好’制錢T··義質酸。由上倾細示,缝幹細胞和 脂肪幹細胞在有軟骨料㈣航下,培養於幾H透明f酸之軟 月基因表現為最高’其次為幾丁聚醣,最低為TCPS。目此,有吸收透 明質酸之幾丁聚醣膜,可大幅增進胎盤幹細胞和脂肪幹細胞聚集形成 —球體細胞群體,且維持胎盤幹細胞和脂肪幹細胞自我更新和幹性, 以及往後增進軟骨的分化能力。 本發明實施例誘導胎盤幹細胞和脂肪幹細胞在薄膜上自發地形成 立體球體’在塗佈透明質酸之幾丁聚醣上形成許多大球體,亦證實透 明質酸能增進球體形成。 實施例6 以幾丁聚醣-銀耳多醣培養脂肪幹細胞、神經幹細胞 m 29 201219572 - 6.1幾丁聚醣-銀耳多醣膜製備 利用實施例5之1%的幾丁聚醣-1(購於Fluka)做為基材,以實施例 5的幾丁聚醣膜製備方法製備,先加入3mg的幾丁聚醣於24孔培養板 的每一孔中,每孔再加入3mg銀耳多醣,比例為1 : 1。 6.2萃取和培養脂肪幹細胞、神經幹細胞 脂肪幹細胞的萃取及培養同實施例5。 神經幹細胞的萃取及培養同實施例2。 _ 6.3脂肪幹細胞、神經幹細胞培養於幾丁聚醣-銀耳多醣膜上的形態 脂肪幹細胞培養於幾丁聚醣-銀耳多醣膜上24小時和48小時的形 態如第十九圖,另外神經幹細胞亦成球形。 幾丁聚醣與銀耳多醣之比例包括但不限於1 : 1,約3 : 0.4至3 : 4.5皆可。 實施例7 以幾丁聚醣、幾丁聚醣-透明質酸、聚己内酯、聚己内酯_透明質酸膜培 養肺幹細胞(lung stem cell, LSC) 7.1歲丁 5^醣、幾丁 t醣-透明質酸、聚己内g旨(p〇iyCapr〇iact〇ne, pcL)、 聚己内酯-透明質酸膜製備 幾丁聚醣、幾丁聚醣-透明質酸脂製備與實施例5相同。 取分子量80kDa之聚己内酯(購於Sigma),溶於丨,4二氧六環 (l,4-di〇Xane),即為11%之聚己内酯。將上述聚己内酯鑄於玻片,即為 聚己内酿薄膜。然後以大氣電漿(能量1 kw,購於德國plasmatreat)以距 離10 mm速度6 m/min掃描後,將3〇〇 ul 2 % mg/mi透明質酸水溶液 滴在上面,隔夜後洗去’透明質酸就會電漿接枝於表面,密度為〇 5 mg/ cm2 〇 [S] 30 201219572 7.2小鼠肺幹細胞(lung stem cell, LSC)之萃取及培養 小鼠肺幹細胞係依據 Ling TY, Kuo MD,Li CL,Yu AL,Huang YH, Wu TJ, Lin YC, Chen SH, Yu J. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci USA. 2006 Jun 20; 103(25):9530-5. Epub 2006 Jun 13,由小鼠肺臟所取得。 7.3肺幹細胞培養於幾丁聚醣、幾丁聚醣-透明質酸、聚己内酯及聚己 内酯-透明質酸膜之結果 肺幹細胞在幾丁聚醣以及幾丁聚醣-透明質酸上會形成球狀,且 nanog/〇ct4基因表現提升。 而在聚己内酯及聚己内酯-透明質酸膜上亦會成球(見第二十圖),聚 己内酯表面呈晶狀排列,故看得到圓晶(似表面龜裂);且幹性基因 nanog/oct4表現提升(第二十一圖)。 因此,該些結果顯示本發明提供之一多能成體幹細胞、其醫藥組 合物、以及用於生產該成體幹細胞的方法,係藉由生物相容性高分子 接觸,確實能達到細胞自我更新及維持幹性(stemness)的突出效果。 【圖式簡單說明】 第一圖係培養於a.明膠和b.組織培養板(TCps)上三天之神經幹細 胞;無任何球體形成。比例尺為ΙΟΟμτη。 第二圖係為培養於不同幾丁聚醣(a•幾丁聚醣_丨b•幾丁聚醣_2)之神 經幹細胞在第1、2、3天之形態;比例尺為1〇〇μηι。 第二圖係為培養於幾丁聚醣-1之神經幹細胞五天後利用掃描式電子顯 微鏡(SEM)結果:a·俯視圖b.側視圖。 第四圖係為第a-3 b.5 c. 7 d l5 e 2〇 f 25天細胞形態⑷和 ί -S] 31 201219572 FIB-螢光綠蛋白表現(右);比例尺為2〇〇啤。 第五圖係為培養於幾丁聚醣-1之神經幹細胞在a F1B_螢光綠蛋白和 b. nestin(免疫染色)第卜4、21天的表現;比例尺為1〇〇μιη。 第八圖係為培養於幾丁聚醣-1之a. DAPI(細胞核)和b· p3-tubulin(免 疫染色)在第4、14、21天之球體形態;比例尺為100|jm。 第七圖係為培養於四種2D褐藻酸鹽膜(a. A#1 b. A#2)之神經幹細胞/ 神經前驅細胞三天後的型態;比例尺為250μτη。 第八圖係為NSPCs培養於褐藻酸鹽薄膜和TCPS上之分化能力比較; TuJl為神經細胞、GFAP為神經膠細胞。 第九圖係為大鼠脂肪幹細胞在TCPS (T)、PVA (P)材料上培養第1天、3 天和第11天的細胞球形態;-:無添加5-aza ; +:添加5-aza 第十圖係為大鼠脂肪幹細胞(rADASs )在Chit〇san3 (CS3)、Chit〇san 1 (CS1)、Chitosanl+CBD_RGD (CS1R)材料上培養第 1 天、3 天 和第Π天的細胞球形態;無添加5-aza ; +:添加5-aza 第十一圖係為大鼠脂肪幹細胞(rADASs )在TCPS (T)、Chit〇san 1 (CSl)、Chitosanl+CBD-RGD (CS1R)材料上利用 RT-PCR 實驗 後的毛細管電泳圖;Cardiomyocyte positive(CP):無添加 5-aza ;+:添加 5-aza。 第十二圖係為人類包皮纖維母細胞培養於A.幾丁聚醣-1,人類牙齦 幹細胞培養於B·幾丁聚醣-1 C.幾丁聚醣-2 D. TCPS 植入三天後之細胞形態;比例尺為ΙΟΟμιη;放大倍率為1〇倍。 第十二圖係為人類牙齦幹細胞培養於幾丁聚醣膜上在植入後Α. 12 Β. Η C· 16 D. 18 Ε. 20 F. 22 G 24小時同—範圍之形 態;比例尺為ΙΟΟμιη,放大倍率為10倍》 第十四圖係為人類牙齦幹細胞培養於幾丁聚醣在植入後第A 〇 B1 C. 2 D. 3天之形態;和培養於TCPS在植入後第E 〇 R1 G2 H.3天之形態;人類牙齦幹細胞培養於〖.含誘導培養。 [] 32 201219572 _ 液之幾丁聚醣j.含基本培養液之幾丁聚醣和κ含誘導 培養液之TCPS L.含基本培養液之TCPS 1天後之形態;, · οχ_9 ' __ and eQUagen coffee increased in the age of soft sputum (the eighteenth figure B, D, F), compared with the culture of the basic culture (the eighteenth a 'c, cut. When the adipose stem cell culture These genes have a high performance (compared to TCPS/basic medium) when there are several y-glycans and chitosan hyaluronic acid in the basic culture medium. On the other hand, when the placental stem cells are cultured in the basic culture medium These genes showed low performance (compared with TCPS/basic culture solution) when riding and a few n days (four) acid. Cultured in chitosan with basic culture solution and chitin-carrying transparent hyaluronic acid The soft tip of the softer than the placenta is fine = better ~ make money T · · lyric acid. From the top, the suture stem cells and adipose stem cells in the cartilage (four) under the air, cultivated in a few H transparent f acid soft moon The gene is expressed as the highest 'the second is chitosan, the lowest is TCPS. Therefore, there is a chitosan membrane that absorbs hyaluronic acid, which can greatly enhance the aggregation of placental stem cells and adipose stem cells - a population of spheroid cells, and maintain placental stem cells And self-renewal and dryness of adipose stem cells, and subsequent enhancement The ability of the bone to differentiate. Inventive embodiments of the invention induce placental stem cells and adipose stem cells to spontaneously form a stereosphere on the membrane. A large number of large spheres are formed on the chitosan coated with hyaluronic acid, and it is also confirmed that hyaluronic acid can enhance the formation of spheres. Example 6 Culture of adipose-derived stem cells and neural stem cells with chitosan-white fungus polysaccharide m 29 201219572 - 6.1 Preparation of chitosan-twinkle polysaccharide membrane 1% of chitosan-1 of Example 5 (purchased from Fluka) As a substrate, prepared by the method of preparing chitosan film of Example 5, first adding 3 mg of chitosan to each well of a 24-well culture plate, and adding 3 mg of Tremella polysaccharide to each well, the ratio is 1 : 6.2 Extraction and culture of adipose stem cells, neural stem cells Adipose-derived stem cells were extracted and cultured as in Example 5. The extraction and culture of neural stem cells were the same as in Example 2. _ 6.3 Adipose-derived stem cells and neural stem cells were cultured in chitosan-white fungus polysaccharide Morphological adipose stem cells on the membrane were cultured on the chitosan-twinkle polysaccharide membrane for 24 hours and 48 hours, as shown in Fig. 19, and the neural stem cells were also spherical. Chitosan and silver The ratio of the polysaccharide includes, but is not limited to, 1: 1, about 3: 0.4 to 3: 4.5. Example 7 Chitosan, chitosan-hyaluronic acid, polycaprolactone, polycaprolactone_ Hyaluronic acid membrane cultured lung stem cells (LSC) 7.1 years old butyl 5^ sugar, chitin t-glycolic acid, hyaluronic acid, polyglycoside (p〇iyCapr〇iact〇ne, pcL), poly-self Preparation of chitosan and chitosan-hyaluronic acid ester by ester-hyaluronic acid membrane was prepared in the same manner as in Example 5. Polycaprolactone (purchased in Sigma) with a molecular weight of 80 kDa was dissolved in hydrazine, 4 dioxane. Ring (l,4-di〇Xane), which is 11% polycaprolactone. The above polycaprolactone is cast on a glass slide, which is a poly-inner film. Then, after scanning at a distance of 10 mm 6 m/min with atmospheric plasma (energy 1 kw, purchased from plasmatreat, Germany), 3 ul of 2% mg/mi aqueous hyaluronic acid solution was dripped on it, and washed away overnight. Hyaluronic acid is grafted onto the surface with a density of 〇5 mg/cm2 〇[S] 30 201219572 7.2 Extraction of mouse lung stem cells (LSC) and culture of mouse lung stem cell lines according to Ling TY, Kuo MD, Li CL, Yu AL, Huang YH, Wu TJ, Lin YC, Chen SH, Yu J. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in Vic. Proc Natl Acad Sci USA. 2006 Jun 20; 103(25): 9530-5. Epub 2006 Jun 13, obtained from mouse lungs. 7.3 results of lung stem cells cultured in chitosan, chitosan-hyaluronic acid, polycaprolactone and polycaprolactone-hyaluronic acid membranes. Lung stem cells in chitosan and chitosan-hyaluronan The acid forms a globular shape and the nanog/〇ct4 gene is improved. On the polycaprolactone and polycaprolactone-hyaluronic acid film, it will also form a sphere (see Figure 20). The surface of polycaprolactone is arranged in a crystal form, so that round crystals (like surface cracks) can be seen. And the performance of the dry gene nanog/oct4 is improved (21st). Therefore, the results show that the present invention provides a pluripotent adult stem cell, a pharmaceutical composition thereof, and a method for producing the same, which are capable of achieving cell self-renewal by contact with a biocompatible polymer. Maintain the outstanding effect of stemness. [Simple description of the schema] The first panel is a neural stem cell cultured on a. gelatin and b. tissue culture plate (TCps) for three days; no spheroid formation. The scale bar is ΙΟΟμτη. The second figure is the morphology of neural stem cells cultured on different chitosan (a• chitosan 丨b• chitosan-2) on days 1, 2, and 3; the scale is 1〇〇μηι . The second panel shows the results of scanning electron microscopy (SEM) after five days of culture of chitosan-1 neural stem cells: a. Top view b. Side view. The fourth picture is the a-3 b.5 c. 7 d l5 e 2〇f 25-day cell morphology (4) and ί -S] 31 201219572 FIB-fluorescent green protein performance (right); scale bar is 2 beer . The fifth figure shows the expression of neural stem cells cultured in chitosan-1 on days 4 and 21 of a F1B_fluorescent green protein and b. nestin (immunofection); the scale bar is 1〇〇μιη. The eighth figure is the sphere morphology of a. DAPI (nucleus) and b. p3-tubulin (immuno staining) on days 4, 14, and 21 of chitosan-1; the scale bar is 100|jm. The seventh figure is the type of neural stem cells/neural precursor cells cultured in four 2D alginate membranes (a. A#1 b. A#2) three days later; the scale bar is 250 μτη. The eighth figure is the comparison of the differentiation ability of NSPCs cultured on alginate film and TCPS; TuJ1 is a nerve cell and GFAP is a glial cell. The ninth image shows the cell morphology of rat adipose stem cells cultured on TCPS (T) and PVA (P) materials on days 1, 3 and 11; -: no addition of 5-aza; +: addition of 5- The tenth figure of aza is the cells of rat adipose stem cells (rADASs) cultured on Chit〇san3 (CS3), Chit〇san 1 (CS1), Chitosanl+CBD_RGD (CS1R) materials on day 1, day and day. Ball morphology; no addition of 5-aza; +: addition of 5-aza. Figure 11 shows rat adipose-derived stem cells (rADASs) in TCPS (T), Chit〇san 1 (CSl), Chitosanl+CBD-RGD (CS1R) The capillary electrophoresis pattern after RT-PCR experiment was used on the material; Cardiomyocyte positive (CP): no addition of 5-aza; +: addition of 5-aza. The twelfth picture shows human foreskin fibroblasts cultured in A. chitosan-1, human gingival stem cells cultured in B· chitosan-1 C. chitosan-2 D. TCPS implantation for three days After the cell morphology; the scale is ΙΟΟμιη; the magnification is 1〇. The twelfth figure is a human gingival stem cell cultured on a chitosan membrane after implantation. 12 Β. Η C· 16 D. 18 Ε. 20 F. 22 G 24-hour same-range form; ΙΟΟμιη, magnification 10 times" The fourteenth figure is the human gingival stem cells cultured in the form of chitin in the first A 〇B1 C. 2 D. 3 days after implantation; and cultured in TCPS after implantation E 〇R1 G2 H.3 days morphology; human gingival stem cells cultured in 〖. containing induction culture. [] 32 201219572 _ Liquid chitosan j. Chitosan containing basic culture solution and κ containing induction culture solution TCPS L. Form of TCPS containing basic culture solution after 1 day;

人類牙齦幹細胞培養於M.含誘導培養液之幾丁聚醣R 含基本培養液之幾丁聚醣和〇.含誘導培養液之TCPS P. 含基本培養液之TCPS在軟骨料後2天之職;人類牙報 幹細胞培養於Q.含誘導培養液之幾丁聚醣R.含基本培養 液之幾丁聚醣和S.含誘導培養液之TCPS τ含基本培養 液之TCPS在軟骨誘導後7天之形態;人類牙齦幹細胞培養 於U.含誘導培養液之幾丁聚醣V.含基本培養液之幾丁聚Human gingival stem cells are cultured in M. chitin containing R-containing medium and chitosan containing basal medium and sputum. TCPS containing induction medium. PPS containing basic medium is 2 days after cartilage Human tooth tube stem cells cultured in Q. Chitosan containing induction medium R. Chitosan containing basic culture medium and S. TCPS containing induction medium, TCPS containing basic culture solution after cartilage induction 7-day morphology; human gingival stem cells cultured in U. containing chitosan in the induction medium. V.

參 膽和w·含誘導培養液之TCPS X.含基本培養液之TCPS 在軟骨誘導後Μ天之形態;比例尺為·μηι,放大倍率為 10倍。 第十五圖係為骨髓間葉幹細胞培養於幾丁聚酿膜上4天後之細胞形態。 第十六圖係為不同幹細胞培養於不同材料上。㈧培養於TCPS之細胞 U (B)培養於含基本培養液之幾丁聚聽和幾丁聚酷-透明 質酸三天後之細胞形態。 第十七圖係為脂肪幹細胞培養於含基本培養液幾丁聚醣和幾丁聚聽_透 籲明質酸和TCPS第10天的幹性基因(〇ct4、s〇x2和Nan〇g)之 mRNA表現量化結果。 第十八圖係秘養於幾丁聚膽和幾丁聚畴_透明質酸膜(與Tcps比較) 在I人月誘導後7天以RT_pCR量化脂肪幹細胞和胎盤幹細胞的 軟骨細胞基因表現。 第十九圖係為培養猶幹細胞於幾了聚醣·料錄贴⑷%小時, 及(Β) 48小時後之形態。 第二十圖係為培養肺幹細胞於聚己内酷、聚己内醋·幾丁聚醋膜上第卜 2天之形態。 第二十-圖係為肺幹細胞培養於聚己内醋、聚己内醋-幾丁聚膽膜上第⑸ 33 201219572 1、3 天幹性基因(actin、Oct4、Sox2 和 Nanog)之 mRNA 表 現結果。 【主要元件符號說明】 無The spleen and w·TCPS containing the inducing culture solution X. The form of the TCPS containing the basic culture solution after the cartilage induction; the scale bar is · μηι, and the magnification is 10 times. The fifteenth figure is the cell morphology of the mesenchymal stem cells cultured on the chitosan membrane for 4 days. The sixteenth figure is the cultivation of different stem cells on different materials. (8) Cells cultured in TCPS U (B) was cultured in the form of cells containing the basic culture solution of chitosan and chitosan-hyaluronic acid for three days. The seventeenth figure is the dry gene (培养ct4, s〇x2 and Nan〇g) of the adipose-derived stem cells cultured on the 10th day containing the basic culture solution of chitosan and chitosan and TCPS. The mRNA shows quantitative results. The eighteenth figure is secreted in chitosan and chitosan _ hyaluronic acid membrane (compared with Tcps). The chondrocyte gene expression of adipose stem cells and placental stem cells was quantified by RT_pCR 7 days after I human induction. The nineteenth figure is the form in which the hepatic cells are cultured for a few hours (4)% of the time, and 48 hours after the (Β). The twenty-fifth figure is the form of culturing lung stem cells on the second day of polyhexanol, hexamidine vinegar and chitosan. The 20th-graph is the results of mRNA expression of lung stem cells cultured in poly-caprol vinegar, poly-caprolactone-polybutyrone membrane (5) 33 201219572 1, 3 days dry genes (actin, Oct4, Sox2 and Nanog) . [Main component symbol description] None

[S] 34 201219572 序列表 <110>國立台灣大學 <120>使成體幹細胞產生爲一球體細胞群體的方法 <130〉 990544-11 <160〉 1 <170> Patentln version 3.3[S] 34 201219572 Sequence Listing <110> National Taiwan University <120> Method for producing adult stem cells as a spheroid cell population <130> 990544-11 <160> 1 <170> Patentln version 3.3

<210> <211> <212> <213〉 1 48<210><211><212><213> 1 48

PRT 人工合成 <220〉 <223〉纖維素結合功能區域-RGD貼附序列(CBD-RGD)-<400> 1PRT Synthetic <220> <223>Cellulose Binding Functional Region-RGD Attachment Sequence (CBD-RGD)-<400> 1

Pro Thr Gin His Trp Gly Gin Cys Gly Gly He Gly Tyr Ser Gly Pro 15 10 15Pro Thr Gin His Trp Gly Gin Cys Gly Gly He Gly Tyr Ser Gly Pro 15 10 15

Thr Val Cys Ala Ser Gly Thr Thr Cys Gin Val Leu Asn Pro Tyr Tyr 20 25 30Thr Val Cys Ala Ser Gly Thr Thr Cys Gin Val Leu Asn Pro Tyr Tyr 20 25 30

Ser Gin Cys Leu Pro Thr Thr Pro Thr Gly Arg Gly Asp Ser Ala Ser 35 40 45Ser Gin Cys Leu Pro Thr Thr Pro Thr Gly Arg Gly Asp Ser Ala Ser 35 40 45

Claims (1)

201219572 七、申請專利範圍: 1. 一種使成體幹細胞產生為一球體細胞群體的方法,包含: 體外培養成體幹細胞於一生物相容性高分子形成的一薄膜上,其中該 生物相容性高分子係為幾丁聚醣、褐藻酸鹽、透明質酸、銀耳多醣、 聚己内酯或其任一組合;以及 收集由成體幹細胞聚集成之一球體細胞群體, 其中s亥球體細胞群體會擴大且具有自我更新及分化(differentiation)為 一體細胞的能力。 φ 2·如申請專利範圍第1項所述之方法’其中該成體幹細胞選自由神經幹 細胞'神經前驅細胞、脂肪幹細胞、牙銀幹細胞、骨髓間葉幹細胞、 肺幹細胞及胎盤幹細胞所組成之群組。 3. 如申請專利範圍第1項所述之方法,其中該生物相容性高分子薄膜可 由塗佈或接枝的方式被覆於任何基材上。 4. 如申請專利範圍第1項所述之方法,其中該生物相容性高分子係為幾 丁聚畴與透明質酸的組合,且幾丁聚聰與透明質酸的比例約為3 . 0.177 至 3 : 4.425(w/w)。 • 5.㈣請專利細第1柄述之方法’其巾該生物相雜高分子係為幾 丁聚醋與銀耳多醣的組合,且幾丁聚_與銀耳多醣的比例約為3 : 至 3 : 4.5 (w/w) 〇 6·如申請專利範圍第1項所述之方法,其中該生物相容性高分子係為聚 己内酯與透明質酸的組合。 7. 如申請專利範圍第i項所述之方法,其中該體細胞為一神經細胞。 8. 如申請專利範圍第2項所述之方法,其中該球體細胞群體進一步具有 分化為一心肌細胞或一軟骨細胞的能力。 201219572 - 9.如申請專利範圍第8項所述之方法,其中當該球體細胞群體為該脂肪 幹細胞時,會分化為該心肌細胞。 10. 如申請專利範圍第9項所述之方法’進-步包含使該脂肪幹細胞與 5-azacytidine接觸,使脂肪幹細胞分化為該心肌細胞。 11. 如申請專利範圍第8項所述之方法,其中當該球體細胞群體為該牙齦 幹細胞、該脂肪幹細胞、或該胎盤幹細胞時’會分化為該軟骨細胞。 12. 如申請專利範圍第U項所述之方法,進一步包含使該牙齦幹細胞、 該脂肪幹細胞、或該胎盤幹細胞與一轉型生長因子P3(TGF_P3)接觸, Φ 使分化為該軟骨細胞。 13. —種具有分化能力的成體幹細胞,係由以下方法所製成,包含: 使一成體幹細胞與一生物相容性高分子形成的一薄膜接觸一段有效 時間,其中該生物相容性高分子係為幾丁聚醣、褐藻酸鹽、透明質酸、 銀耳多醣、聚己内酯或其任一組合; 其中該成體幹細胞會形成一球體細胞群體,該球體細胞群體會擴大並 具有分化為一神經元細胞、神經膠細胞、軟骨細胞或心肌細胞的能力。 14. 如申請專利範圍第13項所述之成體幹細胞,其中該成體幹細胞選自 φ 由神經幹細胞、神經前驅細胞、脂肪幹細胞、牙齦幹細胞、骨髓間葉 幹細胞'肺幹細胞及胎盤幹細胞所組成之群組。 15. 如申請專利範圍第13項所述之成體幹細胞,其中該生物相容性高分 子進一步包含一具有如SEQ ID ΝΟ:1胺基酸序列之纖維素結合功能 區域-RGD貼附序列(CBD-RGD)。 16. 如申請專利範圍第π項所述之成體幹細胞,其中該生物相容性高分 子係為幾丁聚膽與透明質酸的組合,且幾丁聚醣與透明質酸的比例約 為 3 : 0.177 至 3 : 4.425(w/w) » 17. —種醫藥組合物,包含如申請專利範圍第13項所述之成體幹細胞及[ 2 201219572 -一藥學上可接受載體。 —種篩選具有自我更新能力成體幹細胞的方法,包含使候選成體幹細 胞與一生物相容性高分子形成的一薄膜接觸一段有效時間’然後判定 具有形成球體細胞群體的成體幹細胞為具有自我更新能力的成體幹 細胞’其中該生物相容性高分子係為幾丁聚醣、褐蕩酸鹽、透明質酸、 銀耳多膽、聚己内醋或其任一組合。 19.如申請專利麵第18項所述之方法,其中該有效時間較佳為丄日到 4曰。 # 2〇.如申請專利範圍第18項所述之方法,其中該生物相容性高分子薄膜 可由塗佈或接枝的方式被覆於任何基材_上。201219572 VII. Patent Application Range: 1. A method for producing adult stem cells as a spheroid cell population, comprising: culturing adult stem cells in vitro on a film formed by a biocompatible polymer, wherein the biocompatibility The polymer system is chitosan, alginate, hyaluronic acid, tremella polysaccharide, polycaprolactone or any combination thereof; and collecting a population of spheroid cells assembled by adult stem cells, wherein the spheroid cell population Will expand and have the ability to self-renew and differentiate as a unit of cells. Φ 2· The method of claim 1, wherein the adult stem cell is selected from the group consisting of a neural stem cell, a neural precursor cell, a fat stem cell, a dental silver stem cell, a bone marrow mesenchymal stem cell, a lung stem cell, and a placental stem cell. group. 3. The method of claim 1, wherein the biocompatible polymeric film is coated onto any substrate by coating or grafting. 4. The method of claim 1, wherein the biocompatible polymer is a combination of chitin and hyaluronic acid, and the ratio of chitin and hyaluronic acid is about 3. 0.177 to 3: 4.425 (w/w). • 5. (4) Please refer to the method described in the first paragraph of the patent. The biological hybrid polymer is a combination of chitosan and tremella polysaccharide, and the ratio of chitosan to tremella polysaccharide is about 3: to 3 The method of claim 1, wherein the biocompatible polymer is a combination of polycaprolactone and hyaluronic acid. 7. The method of claim i, wherein the somatic cell is a nerve cell. 8. The method of claim 2, wherein the spheroid cell population further has the ability to differentiate into a cardiomyocyte or a chondrocyte. The method of claim 8, wherein when the spheroid cell population is the adipose stem cell, the cardiomyocyte is differentiated. 10. The method of claim 9, wherein the method further comprises contacting the adipose stem cells with 5-azacytidine to differentiate the adipose stem cells into the cardiomyocytes. 11. The method of claim 8, wherein the spheroid cell population is differentiated into the chondrocyte when the gingival stem cell, the adipose stem cell, or the placental stem cell. 12. The method of claim U, further comprising contacting the gingival stem cell, the adipose stem cell, or the placental stem cell with a transforming growth factor P3 (TGF_P3), and Φ is allowed to differentiate into the chondrocyte. 13. An adult stem cell having differentiation ability, which is produced by: contacting an adult stem cell with a film formed of a biocompatible polymer for an effective period of time, wherein the biocompatibility The polymer system is chitosan, alginate, hyaluronic acid, tremella polysaccharide, polycaprolactone or any combination thereof; wherein the adult stem cells form a spheroid cell population, and the spheroid cell population expands and has The ability to differentiate into a neuronal cell, a glial cell, a chondrocyte, or a cardiomyocyte. 14. The adult stem cell according to claim 13, wherein the adult stem cell is selected from the group consisting of a neural stem cell, a neural precursor cell, a fat stem cell, a gingival stem cell, a bone marrow mesenchymal stem cell, a lung stem cell, and a placental stem cell. Group of. 15. The adult stem cell of claim 13, wherein the biocompatible polymer further comprises a cellulose binding functional region-RGD attachment sequence having the amino acid sequence of SEQ ID NO: 1 ( CBD-RGD). 16. The adult stem cell of claim π, wherein the biocompatible polymer is a combination of chitosan and hyaluronic acid, and the ratio of chitosan to hyaluronic acid is about 3: 0.177 to 3: 4.425 (w/w) » 17. A pharmaceutical composition comprising the adult stem cells of claim 13 and [2 201219572 - a pharmaceutically acceptable carrier. - A method for screening adult stem cells having self-renewal ability, comprising contacting a candidate adult stem cell with a film formed by a biocompatible polymer for an effective period of time - and then determining that the adult stem cells having the population of spherical cells are self-determined Renewable ability of adult stem cells 'where the biocompatible polymer is chitosan, browning acid, hyaluronic acid, tremella, polycaprolactone or any combination thereof. 19. The method of claim 18, wherein the effective time is preferably from the next day to four weeks. The method of claim 18, wherein the biocompatible polymer film can be coated on any substrate by coating or grafting.
TW099138813A 2010-11-11 2010-11-11 A method to producing a spheroid population of adult stem cells TWI419970B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW099138813A TWI419970B (en) 2010-11-11 2010-11-11 A method to producing a spheroid population of adult stem cells
CN201110355162.3A CN102533640B (en) 2010-11-11 2011-11-10 Method for generating adult stem cells into spheroid cell populations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW099138813A TWI419970B (en) 2010-11-11 2010-11-11 A method to producing a spheroid population of adult stem cells

Publications (2)

Publication Number Publication Date
TW201219572A true TW201219572A (en) 2012-05-16
TWI419970B TWI419970B (en) 2013-12-21

Family

ID=46341677

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099138813A TWI419970B (en) 2010-11-11 2010-11-11 A method to producing a spheroid population of adult stem cells

Country Status (2)

Country Link
CN (1) CN102533640B (en)
TW (1) TWI419970B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI550088B (en) * 2014-01-16 2016-09-21 國立台灣大學 Method for rejuvenating aged cells and composition thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018501782A (en) * 2014-11-21 2018-01-25 台湾粒線体応用技術股▲ふん▼有限公司 Method and pharmaceutical composition for continuously growing motor neuron progenitor cells
KR101796765B1 (en) * 2015-10-02 2017-11-13 순천향대학교 산학협력단 Compositions containing SPHEROID CELL AGGREGATES for enhance ovary function and preparation method of the same
KR101795633B1 (en) * 2016-05-23 2017-11-10 가톨릭대학교 산학협력단 Method of Forming Spheroids of Stem cell
CN108220230B (en) * 2018-02-01 2022-01-18 上海莱馥医疗科技有限公司 Method for separating and culturing human adipose-derived stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074075A2 (en) * 2004-12-30 2006-07-13 Primegen Biotech, Llc Adipose-derived stem cells for tissue regeneration and wound healing
TWI473879B (en) * 2007-12-07 2015-02-21 Univ Nat Cheng Kung Method for preserving proliferation and differentiation potential of undifferentiated cells
CN101215545A (en) * 2007-12-31 2008-07-09 浙江大学 Method for obtaining neural progenitor cells induced by bone marrow mesenchymal stem cells
US9150829B2 (en) * 2009-03-20 2015-10-06 Agency For Science, Technoloy And Research Culture of pluripotent and multipotent cells on microcarriers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI550088B (en) * 2014-01-16 2016-09-21 國立台灣大學 Method for rejuvenating aged cells and composition thereof

Also Published As

Publication number Publication date
CN102533640B (en) 2015-07-08
CN102533640A (en) 2012-07-04
TWI419970B (en) 2013-12-21

Similar Documents

Publication Publication Date Title
AU2018211308B2 (en) Methods and compositions for in vitro and in vivo chondrogenesis
Lai et al. Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells
US8192987B2 (en) Human dental follicle stem cells and methods for obtaining
Bicer et al. Impact of 3D cell culture on bone regeneration potential of mesenchymal stromal cells
Sordi et al. Three-dimensional bioactive hydrogel-based scaffolds for bone regeneration in implant dentistry
TWI720333B (en) Preparation method of pluripotent stem cell, preparation method of pluripotent stem cell using the preparation method, ameliorating agent, and differentiation induction method of the pluripotent stem cell
Maraldi et al. Human amniotic fluid stem cells seeded in fibroin scaffold produce in vivo mineralized matrix
US20060110825A1 (en) Process for the preparation of stem cells from human muscle tissue and adipose tissue, and stem cell obtainable by this process
TW201014914A (en) Materials and methods for cell growth
TW201219572A (en) A method to producing a spheroid population of adult stem cells
JP2010268715A (en) Use of gene expression group characteristic of dental pulp stem cell of milk tooth
Zhang et al. Comparison of beneficial factors for corneal wound-healing of rat mesenchymal stem cells and corneal limbal stem cells on the xenogeneic acellular corneal matrix in vitro
Su et al. Effect of chitosan conduit under a dynamic culture on the proliferation and neural differentiation of human exfoliated deciduous teeth stem cells
JPWO2008091013A1 (en) Chondrocyte preparation method
CN111254108A (en) Silk protein hydrogel and preparation method and application thereof
WO2022259721A1 (en) Method for producing mesenchymal stem cells
Tangjit et al. Optimal xeno-free culture condition for clinical grade stem cells from human exfoliated deciduous teeth
JP2022189188A (en) Method for producing mesenchymal stem cell
JP2022550911A (en) Chondrogenic human mesenchymal stem cell (MSC) sheet
Daniele et al. Denuded Descemet’s membrane supports human embryonic stem cell-derived retinal pigment epithelial cell culture
US20220265901A1 (en) Method for enhancing activity in a graft
Tong et al. In vitro culture of BMSCs on VEGF-SF-CS three-dimensional scaffolds for bone tissue engineering
Nguyen et al. Scalable and Uniform Fabrication of Dexamethasone-Eluting Depot-Engineered Stem Cell Spheroids as a Microtissue Construct to Target Bone Regeneration
Zhang et al. Osteogenic differentiation of BMSCs in collagen-based 3D scaffolds
Zhao et al. Muscle-derived stem cells differentiate into functional smooth muscle cells for ureter tissue engineering: An experimental study